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Abstract 
The heavily methylated vertebrate genomes are punctuated by stretches of poorly 
methylated DNA sequences that usually mark gene regulatory regions. It is known that 
the methylation state of these regions confers transcriptional control over their 
associated genes. Given its governance on the transcriptome, cellular functions and 
identity, genome-wide DNA methylation pattern is tightly regulated and evidently 
predefined. However, how is the methylation pattern determined in vivo remains 
enigmatic. Based entirely on in silico and in vitro evidence, recent studies proposed that 
the regional hypomethylated state is primarily determined by local DNA sequence, e.g., 
high CpG density and presence of specific transcription factor binding sites. 
Nonetheless, the dependency of DNA methylation on nucleotide sequence has not been 
carefully validated in vivo. 
Herein, with the use of blastula embryos of medaka (Oryzias latipes) as a model, 
the sequence dependency of DNA methylation was rigorously tested in vivo. Statistical 
modelling confirmed the strong statistical association between nucleotide sequence 
pattern and methylation state in the medaka genome. In particular, consecutive CpG 
and CGnull-repeats were found highly enriched within the hypomethylated genomic 
loci of medaka (Chapter 1). However, disruption of these DNA motifs in multiple 
hypomethylated loci using CRISPR-Cas9 failed to induce any change to the local 
hypomethylated state in both F0 and F1 embryos. Moreover, by manipulating the 
methylation state of a substantial number of genomic sequences and reintegrating them 
into medaka embryos, it was demonstrated that artificially conferred DNA methylation 
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states were predominantly and robustly maintained in vivo, regardless of their 
sequences and endogenous states (Chapter 2). 
Hence, despite the observed statistical association, nucleotide sequence was unable 
to autonomously determine its own methylation state in vivo. The results presented 
herein argue against the general presumption of the governance on DNA methylation 
by nucleotide sequence, but instead suggest the involvement of other epigenetic factor(s) 
in defining and maintaining the DNA methylation landscape of vertebrate genomes. 
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General introduction 
Biological importance of nucleotide sequence 
Since the discovery by Frederick Griffith in 1928, it is now beyond doubt that DNA is 
the hereditary molecule that convey genetic information in virtually all organisms. The 
subsequent unravelling of DNA structure by Watson and Crick in 1953, as well as the 
complete decryption of genetic codes by Nirenberg and Leder in 1964 set on an 
avalanche of researches on this simple (as a linear polymer composed of only four types 
of nucleotides as repeating unit), yet highly complicated (as the arrangement, i.e. 
sequence, of nucleotides serves as cryptogram of genetic information), molecule. As is 
stated by Frederick Sanger, the Noble Prize laureate who invented the revolutionary 
“plus and minus” DNA sequencing method (a.k.a. “chain termination” or simply 
Sanger method), in his bibliography (Sanger 2005), “… knowledge of sequences could 
contribute much to our understanding of living matter.” Indeed, the “central dogma of 
molecular biology” put forward by Francis Crick in 1958 laid down the core 
mechanistic framework that links nucleotide sequences to biological phenomena. This 
classical dogma stated that (1) heritable genetic information is hard-coded into the 
DNA molecule as specific sequences/arrangement of nucleotides, (2) when the 
information is retrieved, the DNA nucleotide sequence is transcribed into transportable 
RNA molecule that carries essentially the same nucleotide sequence (except that uracil 
is used in place of thymine on the RNA transcript), and (3) the nucleotide sequence in 
the RNA cassette (which mirrors the DNA template) is then translated into a 
corresponding chain of amino acids, i.e. peptide/protein, which forms specific cellular 
structure or catalyses specific biochemical reaction that leads to specific biological traits. 
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Given the postulated direct governance of phenotype by the nucleotide sequence, most 
of the genetic researches in the past decades have a primary focus of unravelling which 
specific stretches of nucleotide sequence (e.g., genes) along the genome determine 
which biological traits. 
 
Epigenetics: the bridge between genotype and phenotypes 
It is, however, incontestable that nucleotide sequence by itself is not sufficient for 
explaining many fundamental aspects of biology. With the rapid technological 
advancement since the beginning of the 21st century, we can now easily unravel the 
nucleotide sequence of the entire genome of an organism within hours. The bloom of 
genome information has given rise to a whole new, exciting era of biological science, 
and greatly accelerates genetic and medical researches. However, in spite of all the 
technological breakthroughs, it remains poorly understood that how exactly a single 
genome (i.e. from one fertilized egg) can give rise to the diverse cell types that constitute 
the body of a multicellular organism. While the genome has been praised as “the 
blueprint of life”, it is incontestable that complete decryption of the “blueprint” requires 
a lot more than obtaining only the genomic sequence. 
The recent conception of epigenetics has provided a crucial link between the 
static genomic sequence and the dynamics in phenotype (Dunham et al. 2012). Under 
the definition that “[epigenetics is] the study of mitotically and/or meiotically heritable 
changes in gene function that cannot be explained by changes in DNA sequence” (Bird 
2002), epigenetics accounts for all mechanisms that can lead to heritable change to the 
accessibility, hence usability and expression state, of different parts of the genome 
without incurring changes to the underlying nucleotide sequence. Examples of 
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epigenetic mechanisms includes DNA methylation, histone modifications, spatial 
organization of chromatin, to name but a few. It is now known that different cell 
states/types acquire different epigenetic landscapes (a.k.a. “epigenomes”) along 
differentiation, and hence can only utilize different subsets of the same genome, 
resulting in different phenotypes (Waddington 1942, reprinted in 2012; Goldberg et al. 
2007). The existence of epigenetic regulatory mechanisms on top of the genome has 
provided an elegant solution to the aforementioned enigma that the very same genome 
can result in the high level of heterogeneity and complexity as observed among 
individual cells within a multicellular organism. 
 
The epigenetic element under spotlight: DNA methylation 
Among all currently known epigenetics mechanisms, DNA methylation is by far the 
most intensively studied and best understood epigenetic element (Beisel and Paro 2011), 
particularly in vertebrates. DNA methylation is the natural occurring, enzymatically 
catalysed, covalent attachment of methyl group (–CH3) onto DNA molecules. While 
organisms along the evolutionary tree display diverse DNA methylation landscapes, 
higher eukaryotes within a same clade generally possess highly conserved genome-wide 
methylation pattern (Noyer-Weidner and Trautner 1993; Colot and Rossignol 1999). 
Vertebrate animals, in particular, demonstrate peculiar DNA methylomes that have 
drawn most of the research focus for the past two decades. 
In a vertebrate genome, cytosines within the CpG (i.e. 5’-CG-3’) dinucleotide-
context are extensively methylated, while unmethylated CpGs are almost exclusively 
found clustered at high density inside gene regulatory elements, such as promoters and 
enhancers. Having an extensively methylated genome is paradoxical since methylated 
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cytosine is prone to mutation into thymine through spontaneous deamination 
(Holliday and Grigg 1993). It was evidenced that the vertebrate genomes have 
undergone extensive loss of CpGs over the course of evolution due to the mutagenic 
nature of cytosine methylation (Bird 1980). Since mutation is often detrimental, it is 
generally believed that the hypermethyated state of vertebrate genomes must confer 
critical biological functions that outweigh the elevated risk of mutation (Bird 1980). 
Intensive researches for the past two decades suggest that gene expression is 
tightly linked to the DNA methylation state within gene regulatory regions. 
Mechanistic studies have proven that DNA methylation governs gene expression by 
preventing binding of methylation-sensitive transcription activators, attracting 
transcription repressors, as well as inducing stable compacting of chromatin (i.e. 
heterochromatin) that precludes the access of transcription machinery (Siegfried and 
Cedar 1997). DNA methylation was also shown to be crucial in suppressing the activity 
of transposable elements, which constitute a significant portion of the vertebrate 
genomes (Slotkin and Martienssen 2007), and, thereby, help maintain genome stability. 
The importance of DNA methylation in vertebrates is further highlighted by the study 
of Li et al. (1992) that genome-wide depletion of DNA methylation in mice, via 
knockout of DNMT1 (i.e. DNA methyltransferase 1; Also known as the “maintenance” 
enzyme that copies methylation state from the template strand to nascent strand during 
DNA replication), is lethal in early embryogenesis. Moreover, aberrant changes in 
methylation pattern are commonly found associated with cellular dysfunction, 
developmental abnormality, and a spectrum of diseases (Robertson and Wolffe 2000; 
Egger et al. 2004). It is now beyond doubt that DNA methylation is of vital importance 
to vertebrates that it directly governs cell state and identity. 
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Furthermore, DNA methylation is, at the time of this writing, the only known 
epigenetic element that can be faithfully inherited (in a semiconservative manner as the 
underlying DNA) during DNA replication. This unique property allows DNA 
methylation to precisely convey epigenetic information across cell division and along 
cell lineage. Given its inheritability, it is believed that DNA methylation may serve as 
the ultimate epigenetic mark that restores or guides the establishment of other 
epigenetic signatures after cell division (Jin et al. 2011). Consequently, unravelling the 
logic of DNA methylation patterning is fundamental to thorough understanding of the 
establishment of- and regulation on the entire epigenome. 
 
Establishment and regulation of DNA methylome 
Given its vital importance, the methylation landscape has to be precisely specified and 
modulated. The DNA methylation pattern is established and maintained through 
highly dynamic biological processes, in which the methylome undergoes substantial, 
yet precise, changes. For instance, differentiating cells faithfully acquire specific 
methylation landscapes that are unique to their committed cell types (Spivakov and 
Fisher 2007; Mohn et al. 2008; Houseman et al. 2012). Remarkably, in human and mice, 
the DNA methylomes are extensively erased and fully reconstituted during 
gametogenesis and early embryonic development (Wu and Zhang 2010; Kohli and 
Zhang 2013). These facts suggest that the methylation landscape is pre-defined by 
genetic information. Deciphering how the methylation pattern is encoded is a 
prerequisite for understanding of differentiation processes and the pathogenesis of 
various diseases. Yet, by what means the methylation pattern is defined and established 
in vivo (i.e. inside a living vertebrate animal) remains enigmatic. 
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Given that CpG dyads are predominantly methylated unless they are clustered 
at high density (Lister et al. 2009), it is generally presumed that hypermethylation is the 
“default” state of vertebrate genomes and specific regions (i.e. gene regulatory elements) 
are protected from de novo methylation, rendering them hypomethylated (Bird 2002; 
Edwards et al. 2010; Lienert et al. 2011; Reeve and Black 2013; Schübeler 2015; 
Takahashi et al. 2017). Intensive researches for the past decade have demonstrated that 
the protection on the genomic loci is possibly mediated by nucleosome positioning 
(Jones and Liang 2009; Jones 2012; Baubec et al. 2015) and/or the recruitment of a 
myriad of proteins (C. Xu et al. 2011; Y. Xu et al. 2011; Wu et al. 2012; Kohli and Zhang 
2013; Marchal and Miotto 2015; Castillo-Aguilera et al. 2017) which eventually (1) 
block off local access of DNA methyltransferases or (2) remove methylation on 
cytosines in vicinity through oxidation and thymine DNA glycosylase (TDG)-mediated 
base excision repair. However, little is known about how these factors are specifically 
predisposed on the preselected loci. 
Recent researches proposed that DNA methylation pattern is ultimately 
governed by local sequence context. In particular, in silico analyses asserted that there 
is strong statistical association between sequence variants and differential DNA 
methylation states in vertebrates, from fish (Uno et al. 2016) to human (Kaminsky et al. 
2009). A number of recent in vitro studies, which utilized mammalian cell lines that had 
been stably maintained in dishes or flasks, further demonstrated that high CpG density 
and/or the presence of specific transcription factor binding sites is capable of 
autonomously determining local hypomethylation in the globally methylated genome 
(Lienert et al. 2011; Stadler et al. 2011; Krebs et al. 2014; Takahashi et al. 2017). These 
recent in silico and in vitro reports propel the notion that DNA methylation pattern is 
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primarily and autonomously determined by local sequence context (Lienert et al. 2011). 
However, the anticipated sequence-dependency of DNA methylation is in 
contradiction to the pioneer in vitro experiments in early days of DNA methylation 
researches (Pollack et al. 1980; Wigler 1981; Stein et al. 1982), in which the methylation 
status of exogenous DNAs (either artificially CpG-methylated or completely 
unmethylated) was found maintained for many cell generations upon stable genome 
integration. Given the opposing results, whether or not the DNA methylation landscape 
is autonomously determined by the underlying genomic sequence appears to be less 
concrete than what has recently been proposed. Moreover, the postulated relationship 
between DNA methylation landscape and local sequence context has never been 
rigorously validated in vivo. 
 
Experimental outline 
Given the above contentious in vitro findings and a void of in vivo proof for the 
postulated sequence-dependency in the patterning of DNA methylation landscape, this 
research project was conceived with a primary objective to rigorously test the 
governance of genomic sequence on its own DNA methylation state in vivo. The small 
laboratory fish, medaka (Oryzias latipes), was chosen as an experimental model for their 
relatively small genome size (approx. 700 Mbp), ease of in vivo genetic manipulation, 
oviparity, in addition to their capability of producing 10–20 fertilized embryos per pair 
on daily basis (Kinoshita et al. 2009; Kirchmaier et al. 2015). These traits enabled the 
use of large number of embryos for in vivo experimentation (Chapter 2), which is hardly 
feasible with conventional mammalian models, such as rodents. The blastula stage was 
specifically chosen as the endpoint in all experiments throughout this study due to its 
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homogenous cell type composition (i.e. mostly pluripotent cells) and the ample amount 
of genetic materials (2000–4000 diploid cells, i.e. 4000–8000 copies of the genome, per 
embryo) available for precise methylation state measurements. The experiments, as 
documented and structured in this dissertation, aimed to: 
1. (Chapter 1) demonstrate that the medaka genome also displays the 
characteristic, strong statistical association between DNA methylome and 
genomic sequence as observed in aforementioned mammalian-based in silico 
studies. This observation not only validates the medaka as a suitable vertebrate 
model for the study on sequence-dependency of DNA methylation, but also 
highlights that the anticipated linkage between the DNA methylome and the 
underlying genomic sequence is a conserved feature along the evolution of 
vertebrates, from fish to mammals. And, 
2. (Chapter 2) scrutinize whether genomic sequences can autonomously 
determine their own DNA methylation state via large-scale genetic engineering, 
including the use of genome and methylome editing, in vivo. 
As presented herein, the results suggest that nucleotide sequence, by itself, cannot 
dictate its own methylation state in vivo in medaka, which apparently contradicts the 
prevailing view of DNA methylation in vertebrates and call for a new wave of pursuit 
of factors that genuinely determine the vertebrate DNA methylome. 
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Chapter 1     Statistical association between genomic 
sequence and DNA methylation state in vivo 
 
1.1 Introduction 
Since the dawn of bioinformatics, there has been unceasing endeavours and ever-
accumulating informatics tools crafted to help predict or identify the functional role of 
any particular segments of genome in silico. Many of these computational tools could 
predict the locations of genes (Mathe 2002; Stanke and Waack 2003; Mount 2004; 
Wasserman and Sandelin 2004) and their regulatory regions (Pedersen et al. 1999; 
Scherf et al. 2000; Bajic et al. 2002; Noble et al. 2005; Fiedler and Rehmsmeier 2006; Su 
et al. 2010; Lee et al. 2015) with satisfactory accuracy and sensitivity, greatly facilitating 
further functional characterization of the genomes. 
The success behind all these prediction attempts is underpinned by the fact that 
genomic loci that serve similar functions frequently share similar nucleotide sequence 
patterns. For instance, many eukaryotic promoters contain binding sequences of the 
general transcription factors (TFs) that involve in transcription initiation, e.g., TATA 
element (canonical sequence: 5’-TATAAA-3’) that is recognized by TATA-binding 
protein; B recognition element (canonical sequence: 5’-SSRCGCC-3’, where S = C or G, 
R = A or G) that is recognized by Transcription Factor II B; E-box (canonical sequence: 
5’-CACGTG-3’) that is recognized by a wide range of TFs of the basic helix-loop-helix 
(bHLH) family. Similarly, the exon-intron boundaries inside most open reading frames 
are characterized by the presence specific sequences, e.g., consensus sequences of 5’-
MAGGTRAGT-3’ (where M = A or C) and 5’-CAGG-3’ in the 5' and 3’ splice sites, 
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respectively, of all U2 introns (the major class of intron). In other words, conserved 
patterns of nucleotide sequence are repeatedly and extensively used along the genome 
to encode conserved, pre-specified genetic information. 
 The DNA methylation states in multiple mammalian cell types have also been 
repeatedly shown to strongly correlate with, hence highly predictable by, underlying 
nucleotide sequences (Bhasin et al. 2005; Rollins 2005; Bock et al. 2006; Das et al. 2006; 
Fang et al. 2006; Wang et al. 2006; Bock and Lengauer 2008; Fan et al. 2008; Kim et al. 
2008; Previti et al. 2009; Xie et al. 2012; Zhou et al. 2012; Zheng et al. 2013; Ma et al. 
2014; Zhang et al. 2015; Angermueller et al. 2017). In particular, locally high CpG 
density is proven to be the molecular signature of hypomethylated regions (Krebs et al. 
2014; Takahashi et al. 2017). The widely observed statistical linkage between DNA 
methylation state and sequence forms the logic basis of the general belief that local 
methylation state is encoded by nucleotide sequence (Bock et al. 2006; Edwards et al. 
2010). 
 However, such dependency between DNA methylation and sequence was 
inferred from the analyses of human and mouse genomes only and has never evidenced 
in any non-mammalian species. From the evolutionary standpoint, the acquisition of 
genome-wide hypermethylation is the hallmark event that underpinned the advent of 
vertebrates from their invertebrate ancestors (Bird 1995). Coupling with the fact that 
the overall genome-wide methylation landscape appears to be highly similar among 
vertebrate species (globally methylated with specific gene regulatory regions rendered 
hypomethylated), the molecular logic underlying the patterning of DNA methylome is 
also likely conserved through vertebrate evolution. Yet, it remains uncertain whether 
different clades of vertebrates (i.e. fish, amphibians, reptiles, bird, and mammals) share 
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similar degree of sequence-dependency in methylation state determination. Such 
uncertainty severely undermines the generalisability of the notion that DNA 
methylome is defined by genomic sequence in vertebrates.  
 In order to evident the expected association between genomic sequence and 
DNA methylation in non-mammalian vertebrate species, the statistical linkage between 
the genome and the methylome of medaka (i.e. a teleost) was determined. Specifically, 
differential sequence composition in hypomethylated (a.k.a. hypomethylated domains, 
“HypoMDs”) and hypermethylated loci (a.k.a. hypermethylated domains, 
“HyperMDs”) in the medaka genome is revealed and modelled by machine learning. 
Support vector machine (SVM) was chosen for this purpose since it is by far the most 
frequently used machine learning algorithm for the classification/prediction of DNA 
methylation state with respect to nucleotide sequence and has shown consistently high 
accuracy and sensitivity (Bhasin et al. 2005; Bock et al. 2006; Das et al. 2006; Fang et al. 
2006; Fan et al. 2008; Previti et al. 2009; Zhou et al. 2012; Zheng et al. 2013; Ma et al. 
2014). 
The results described in this chapter ascertain that the strong correlation between 
local DNA methylation state and the underlying nucleotide is not restricted to 
mammals, but can also be found in a teleost (i.e. the medaka). This finding suggests that 
the expected coupling of nucleotide sequence and its methylation state is a conserved 
genomic feature among the clade of vertebrates. 
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1.2 Results 
1.2.1 HypoMDs and HyperMDs contain distinct sequence patterns 
Statistical association between medaka genomic sequences and local methylation states 
was modelled using support vector machine (kmer-SVM) (Fletez-Brant et al. 2013). 
HypoMDs and HyperMDs at the blastula stage (Stage 11 according to Iwamatsu, 2004) 
were identified by the same criteria as described by Nakamura et al. (2014) (see also 
Figure 1.1, as well as Materials and Methods). While HypoMDs and HyperMDs are not 
readily discernible in terms of length (Figure 1.2A) and GC composition (Figure 1.2B), 
they bear conspicuous difference in their sequence pattern, allowing robust 
classification and prediction of the methylation states based solely on nucleotide 
sequence information (Figure 1.1: “SVM classification” track, c.f. “HyoMD” and 
“HyperMD” tracks; Figure 1.3A: area under precision-recall curve ≥ 0.83, versus 0.08 
from the random classifier; Figure 1.4A: maximum Matthew’s correlation coefficient = 
0.76). 
 Since HypoMDs have a higher average CpG density than HyperMDs (Figure 
1.2C), CpG density might act as a confounding factor that outweighs and conceals non-
CpG-containing sequence features. The impact of CpG density was, hence, controlled 
for by masking all CpG dinucleotides (i.e. from ‘CG’ to ‘NN’) and SVM models were 
retrained. Conspicuously, CpG-masking could still result in models with modest 
classification performance (Figure 1.3B: area under precision-recall curve ≥ 0.53, versus 
0.08 from the random classifier; Figure 1.4B: maximum Matthew’s correlation 
coefficient = 0.51), suggesting that CpG-free DNA motifs are also differentially 
enriched in HypoMDs and HyperMDs. 
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1.2.2 Consecutive CpG and CGnull-repeat are strongly enriched in HypoMDs 
The weight of individual k-mers (i.e. 6-mer in this case) in kmer-SVM model directly 
reflects the relative importance of the corresponding sequence in the 
classification/prediction of the methylation states. Since the weight of each of the k-
mers is mathematically assigned as a function of relative enrichment in HypoMDs 
versus that in HyperMDs, these values were used to identify consensus patterns that are 
overrepresented in HypoMDs. Of all 2080 possible canonical 6-mers, those with 
consecutive CGs were highly overrepresented in HypoMDs (odd ratio = 9.54; Figure 1.5: 
the 3rd – 4th lanes versus the 2nd lane; see also Table 1). On the other hand, as revealed by 
SVM modelling after CpG masking, specific 6-mers that contain no CpG are also found 
highly enriched in HypoMDs (Table 1: right columns). Interestingly, the top most 
enriched, CpG-free 6-mers are all derived from the same, but shifted, repeat pattern of 
(AGCT)n, where n ≥ 1.5 (i.e. ≥ 6 bp): AGCTAG, GCTAGC (palindromic), CTAGCT (a 
reverse complement of AGCTAG), or TAGCTA (palindromic) (odd ratio = 2.50; 
Figure 1.5: the 6th lane; see also Table 1). For the sake of simplicity, these 6 bp-long, 
CpG-free repeating sequences are collectively referred to as “CGnull-repeats” from here 
onwards. 
 
1.2.3 Only a small subset of the enriched motifs could be linked to 
transcription factor binding sites 
To further identify whether consecutive CpGs and CGnull-repeats could be the 
recognition/binding sequences of transcription factors, the 6-mers that are highly 
enriched in HypoMDs and contain consecutive CpG or CGnull-repeat were matched 
against databases of vertebrates’ transcription factor binding sites using TomTom (part 
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of the MEME Suite) (Gupta et al. 2007). However, among all 56 valid 6-mers (52 with 
CGCG, 1 CGCGCG, and 3 CGnull-repeats), only 7 motifs (GCGCGC, CGCGCG, 
CGCGGA, CGCGCA, CCGCGG, CCCGCG, and CGCGCC) could be confidently 
mapped to 3 known transcription factor binding sites: ZBTB14, E2F2, and E2F3 (Figure 
1.6). CGnull-repeats could not be matched to any known transcription factor binding 
site regardless of statistical stringency. 
 
1.3 Discussion 
This study is the first to demonstrate that there is the strong statistical association 
between nucleotide sequences and local methylation states in a non-mammalian 
genome. By means of statistical modelling, it is clearly shown that the HypoMDs and 
HyperMDs in medaka genome are characterized by distinctly different sequence 
patterns, allowing highly precise and sensitive in silico classification/prediction of local 
methylation state based solely on nucleotide sequence information. This indicates that 
the anticipated linkage between DNA methylome and the underlying genomic 
sequence is not exclusive to mammals, but also exists in teleost, hence possibly a 
conserved genomic feature among vertebrate animals. 
While the findings as presented herein fully agree with all previous in silico 
studies on mammalian genomes that high CpG density is a common feature of 
HypoMDs, the above SVM results further highlight that the “high CpG density” is 
frequently manifested as consecutive CpGs in the medaka genome. Such feature is not 
unique to medaka. A previous study on mice oocytes’ methylome (Saadeh and Schulz 
2014) also showed that genomic regions resistant to de novo methylation are enriched 
with the 5’-CGCGC-3’ motif. The authors further demonstrated that this motif was 
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indeed bound by E2F1/2 transcription factors, which concurs with the above in silico 
motif analyses. While direct and mechanistic relationship between E2F family proteins 
and DNA methylation is yet to be identified, E2F1–3 are known to be capable of 
inducing H3 and H4 acetylation, as well as indirectly interacting with SWI/SNF 
chromatin remodelling complex, which, in both cases, can lead to protection of local 
DNA from de novo DNA methyltransferases (Saadeh and Schulz 2014), resulting in a 
local hypomethylated state. 
Intriguingly, despite all possible DNA sequence patterns that contain 
consecutive CpGs are highly enriched in HypoMDs, only a small subset of those motifs 
is known/predicted to be associated with TF(s). While this could be due to the fact that 
the binding sequences have not been exhaustively characterised for all TFs, this might 
also indicate that the chained CpGs may play a role other than as a recognition target 
of TFs. Indeed, it has long been recognized that a succession of CpG has critical impacts 
on the local conformation of DNA molecule by destabilizing the B-form (the most 
common double helical structure of DNA) and favouring the formation of Z-form 
DNA (Drew and Dickerson 1981; Tran-Dinh et al. 1983; Shakked and Rabinovich 1986; 
Peticolas et al. 1988). Z-form DNA has been found associated with transcriptional 
initiation and is stably bound by a myriad of DNA binding proteins with high affinity 
(Rich and Zhang 2003). Since the biological functions of Z-DNA remain poorly studied, 
it is largely unknown if Z-DNA can directly regulate local DNA methylation. However, 
it is possible that the binding between Z-form DNA and its recognising proteins can 
physically hinder the local attachment of DNA methyltransferases, thereby protecting 
the local region from methylation. 
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The above SVM results also highlight that certain CpG-free DNA motifs, 
especially the CGnull-repeats, might be associated with the hypomethylated state in 
HypoMDs. As introduced in General Introduction, methylated cytosines are prone to 
spontaneous mutation into thymine. It has been reasoned that the natural conversion 
of methylated CpG into TpG (or CpA on the reverse strand) over an evolution time 
scale eventually led to a depletion of CpGs in HyperMDs, while unmethylated CpG 
within HypoMDs were not affected (Bird 1980). Consequently, the widely observed 
“enrichment” of CpGs within HypoMDs could possibly be a statistical illusion caused 
by the historical loss of CpGs elsewhere in the genome (i.e. methylation states caused 
the relative “enrichment” of CpGs in HypoMDs, but not the other way around), 
opposing the recently postulated role of high CpG density as a determinant of local 
hypomethylation. However, this argument cannot explain the observed enrichment of 
non-CpG-containing DNA motifs in HypoMDs as cytosines outside the context of 
CpG dinucleotide are rarely methylated, and, thus, not susceptible to deamination and 
conversion into thymine. Hence, the overrepresentation of CpG-free sequence patterns 
inside HypoMDs reinforces the notion that local methylation state is closely linked to 
the underlying sequence pattern. Nonetheless, the biological function(s) of these non-
CpG-containing patterns remain obscured. In fact, this study is the first report on the 
statistical enrichment of CpG-free sequence patterns, in particular the CGnull-repeats, 
in HypoMDs of a vertebrate genome. The biological roles of these peculiar DNA motifs, 
as well as their association with HypoMDs, deserve future investigation. 
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1.4 Chapter conclusion 
By the use of statistical modelling, the DNA methylation landscape of medaka genome 
was unveiled to be strongly associated with the underlying genomic sequence. 
HypoMDs and HyperMDs carry distinctly different sequence patterns that cannot be 
completely accounted for by their differential CpG density. In particular, consecutive 
CpGs and CGnull-repeats were found highly enriched in HypoMDs, suggesting their 
relationship with the local hypomethylated state. The above results concur with the 
general belief that DNA methylation landscape is primarily determined by genomic 
sequence. However, it should be noted that statistical association does not necessary 
imply causal relationship. Therefore, to scrutinize the postulated dependency of DNA 
methylome on genomic sequence in vivo, a series of experiments was specifically and 
carefully designed and conducted as documented in the next chapter. 
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Figure 1.1    Genome browser view of a representative locus (approx. 62 kb) in the HdrR medaka genome showing CpG methylation 
rate, called HypoMDs and HyperMDs, SVM classification results, as well as DNase I hypersensitivity and called DNase I hypersensitive 
sites (“DHS”). 
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Figure 1.2    Violin plots showing the distribution of (A) length, (B) GC content, and (C) CpG density of HypoMDs and HyperMDs. 
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Figure 1.3    Precision-recall curves of the kmer-SVM models trained for binary classification of HypoMDs and HyperMDs. 
(A) Without- or (B) with- CpG-masking. HypoMD and HyperMD sequences were assigned to positive and negative classes, respectively. Solid, 
colored lines are individual precision-recall curves derived from 10-fold cross-validation. The colors represent the cut-off values for binary 
classification. Area-under-curve (AUC): (A) minimum = 0.83, maximum = 0.84; (B) minimum = 0.53, maximum = 0.56. Random classifier is 
represented by horizontal dashes at the bottom of both panels and has an AUC of 0.08.
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Figure 1.4    Matthew’s correlation coefficients (MCC) of the kmer-SVM models trained for binary classification of HypoMDs and 
HyperMDs 
(A) without- and (B) with- CpG-masking. HypoMD and HyperMD sequences were assigned to positive and negative classes, respectively. Lines 
represent the MCC derived from individual round of 10-fold cross-validation across various cutoff values. Maximum MCC attained: (A) 0.76, (B) 
0.51.
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Figure 1.5    Compact representation of CpG and CGnull-repeats enrichment 
inside all 2080 possible canonical 6-mers. 
The 6-mers (i.e. individual rows) are sorted vertically according to their importance (i.e. 
SVM weights) in classifying/predicting HypoMDs and HyperMDs. The 6-mers that are 
more important (i.e. higher absolute weight) in the classification/prediction are ranked 
towards the top and bottom, respectively. The ranked 6-mers (rows) are annotated 
according to their CpG and CGnull-repeat content with golden lines in the applicable 
columns. For instance, the 6-mer “CGAACG” (having 2 non-consecutive CpGs) would 
be highlighted gold in the 1st and 2nd column, whereas “AACGCG” (having 2 
consecutive CpGs) would be highlighted gold in the 1st and 3rd column. Note that 6-
mers with consecutive CpGs (the 3rd and 4th column) are highly enriched in HypoMDs. 
White arrowheads in the 4th and 6th lane denote the golden lines that represent (CG)3 
and CGnull-repeats, respectively. 
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Figure 1.6    Binding sequence of (A) ZBTB14, (B) E2F2, and (C) E2F3. 
Note that all three motifs contain a series of interleaving cytosine and guanine at the 
center.
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Table 1    The 30 canonical 6-mers with the highest absolute weights in the SVM 
model trained for classifying/predicting HypoMDs and HyperMDs. 
The lists are sorted according to the absolute weights in descending order. Solitary 
and consecutive CpGs are coloured orange and red, respectively. The 6-bp CGnull-
repeats, i.e. AGCTAG, GCTAGC, CTAGCT (reverse complement of AGCTAG), and 
TAGCTA, are coloured purple. 
 
Without CpG-masking CpG-masked 
Weighed towards 
HypoMDs 
Weighed towards 
HyperMDs 
Weighed towards 
HypoMDs 
Weighed towards 
HyperMDs 
kmer Weight kmer Weight kmer Weight kmer Weight 
GCGCGC 9.05 ACGCCA -4.11 GCTAGC 10.54 AAATTT -7.06 
AAAACG 8.59 AAACGG -4.06 AGCTAG 9.26 AAATTG -5.27 
ACGCGC 8.21 AAACGT -3.82 TAGCTA 6.75 AAAAAT -4.31 
CGCGCG 8.11 CTCGCC -3.61 GCTAAC 6.25 AAATTC -4.01 
ATGCGC 6.86 AAACGC -3.24 CAAAAA 5.02 AAGCTT -3.78 
CGCGAG 6.59 CACTAC -3.09 ACTTAC 4.75 ATATTG -3.56 
CGTTTA 6.46 ATCGCA -2.74 AGCTAA 4.54 CCCTAG -3.51 
CGCGGA 5.88 GGCCCA -2.69 GAAAAA 4.28 GCTAGA -3.41 
GCGCGA 5.80 ATACGC -2.68 ACTCAC 4.27 AAAAAC -3.32 
CGTTTC 5.64 CAACCG -2.64 CTTACC 4.24 GCCCTA -3.25 
TGCGCA 5.36 AGCGTA -2.59 AAGAAG 3.66 AAAAAG -3.19 
CAAACG 5.27 CCCCCA -2.54 TTTAAA 3.45 AAGGCC -3.17 
GCTAGC 5.24 CCCTAG -2.43 CTAGCA 3.45 AAGCAC -3.15 
GCGCAC 5.08 AGAGCG -2.39 AATTTA 3.26 CATGTA -3.07 
CGCGCA 5.00 AACCGT -2.36 AGGTAA 3.24 GAGCTA -3.06 
CGGAAG 4.98 ACCGTA -2.32 TTAAAA 3.23 GACATA -3.05 
ACGCGG 4.92 AAGGCC -2.28 ATCATG 3.19 ACTATG -3.03 
TACGCA 4.87 GCTCTA -2.24 TAAAAA 3.15 GCTCTA -2.98 
GCGTAA 4.66 CGCCTA -2.24 CTAAAA 3.12 CACTAC -2.95 
AGCTAG 4.65 GGGTCA -2.23 AGGGGG 3.09 AGGTCA -2.94 
CCGGAA 4.54 AAATTT -2.19 AATGAA 3.05 AGGCCC -2.91 
CACGTG 4.48 ATGGGG -2.19 AGGCTA 3.01 GAGGCC -2.85 
CCGCGG 4.44 CTCGTA -2.19 GAATAA 2.99 ACATTG -2.81 
TAGCTA 4.35 ACGGAT -2.17 AGCAAA 2.98 AAGCCT -2.81 
CCGCGC 4.33 CACGTC -2.16 CTTAGC 2.92 CATTTC -2.76 
CTGCGC 4.27 CGCTCA -2.16 AGGCTG 2.90 CACTGG -2.72 
CTTACC 4.24 AACCCT -2.14 GGAAAA 2.89 AACCTT -2.69 
GCGCAA 4.22 AAGCCG -2.12 AGTGAA 2.77 ACATGC -2.68 
AATTCG 4.17 GTGTGA -2.11 TCAAAA 2.73 CCCATA -2.67 
GCGGAA 4.11 GGCACC -2.11 CTCACC 2.68 CTAGGA -2.67 
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Chapter 2     Interrogation of the autonomy in DNA 
methylation determination by genomic sequence 
 
2.1 Introduction 
As detailed in the previous chapter, DNA methylation state along vertebrate genomes 
can be robustly predicted using local nucleotide sequence information alone. In silico 
analyses by previous studies on mammalian genomes, as well as by this study on the 
medaka genome, clearly demonstrated that hypomethylated and hypermethylated 
genomic loci are indeed characterized by distinct nucleotide sequence composition, 
which underpins the high precision and sensitivity achieved by the in silico predictions 
of local methylation state. The strikingly strong statistical association between local 
methylation state and nucleotide sequence suggests that nucleotide sequence is 
associated with, or even directly determine, the patterning of the DNA methylation 
landscape. 
 As briefly reviewed in General Introduction, a number of recent in vitro studies 
have provided critical experimental evidence for the anticipated causal relationship 
between DNA methylation and the underlying nucleotide sequence (Lienert et al. 2011; 
Stadler et al. 2011; Krebs et al. 2014; Takahashi et al. 2017). Most importantly, these in 
vitro reports further highlighted that local hypomethylation is autonomously 
determined by the locally high CpG density (Krebs et al. 2014; Takahashi et al. 2017) 
and/or the presence of specific transcription factor bind sites (Lienert et al. 2011; Stadler 
et al. 2011; Krebs et al. 2014). Yet, the above in vitro observations were all made on 
cultured embryonic stem cells (ESCs). It is irrefutable that ESCs are very versatile in 
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vitro experimental models and have repeatedly enabled important discoveries in 
relation to the mechanistic actions of multiple epigenetic machinery (Dawlaty et al. 
2014; Baubec et al. 2015). Yet, their use in the characterization of the molecular logic 
behind the patterning of DNA methylation landscape is dubious as cultured ESCs are 
known to have a high degree of epigenetic instability (Rebuzzini et al. 2016). More 
alarmingly, the use of mouse ESCs (Lienert et al. 2011; Stadler et al. 2011; Krebs et al. 
2014; Takahashi et al. 2017), in particular, is unjustifiable. This is because mouse ESCs 
can thrive normally with a demethylated genome (Tsumura et al. 2006), which is in 
stark contrast to human ESCs (Liao et al. 2015) and early mouse embryos (Li et al. 1992) 
that major loss of CpG methylation is guaranteed to be lethal. Therefore, the 
unconventional epigenetic characteristics of ESCs call into question the generalizability 
of the aforementioned in vitro findings. 
 Moreover, the anticipated dependency of DNA methylome on genomic 
sequence has never been carefully validated in a proper genetic context in vivo. Long et 
al. (2016) were among the first to attempt to gain insight into the sequence dependency 
of DNA methylation in vivo. These authors examined the DNA methylation state of the 
42-Mbp fragment of human chromosome 21 in the Tc1 trans-chromosomic mice and 
showed that the hypomethylated regions that are natively found in human remained 
poorly methylated in Tc1 mice. In addition, they demonstrated that natively 
hypomethylated mouse genomic sequence also remained unmethylated after being 
transposed into the zebrafish genome. Based on these results, the authors inferred that 
in vivo hypomethylated state is autonomously conferred by evolutionarily conserved 
sequence signatures. Notwithstanding, their observations were made on non-native 
sequences (i.e. examining human genomic sequence in mouse, or mouse genomic 
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sequence in zebrafish), and their method-of-choice, i.e. Bio-CAP, had a strong bias 
towards sequences with high CpG density, intrinsically underrepresenting loci that 
were less dense in CpG (Blackledge et al. 2012). Likewise, Li et al. (2015) examined the 
methylation status of one, and only one, transgene across three generations in rat and 
found the stable acquisition and inheritance of DNA methylation pattern, but the 
transgene examined was composed of a mouse promoter and human gene. Thus, it is 
difficult to draw a general conclusion with these studies on the causal relationship 
between DNA sequence and methylation in native context in vivo. 
 Therefore, a cascade of experiments, as documented in this chapter, was 
specially designed and conducted to rigorously scrutinize the long-anticipated 
sequence dependency of DNA methylation in vivo. Specifically, these experiments 
aimed to (1) validate if the HypoMDs in the medaka genome is genuinely conferred by 
the highly enriched DNA motifs as identified by the statistical modelling in Chapter 1, 
namely the consecutive CpGs and CGnull-repeats that are highly enriched in 
HypoMDs, and (2) examine if native (i.e. medaka) genomic sequences can 
autonomously determine their own methylation state in vivo. Unexpectedly, in spite of 
the strong statistical association, the results suggest that nucleotide sequence, by itself, 
cannot dictate its own methylation state in medaka in vivo. 
 
2.2 Results 
2.2.1 Disruption of (CG)3 and CGnull-repeat did not lead to de novo DNA 
methylation of HypoMDs in F0 blastula embryos 
To verify if there is any causal relationship between the local hypomethylated state and 
the presence of consecutive CpGs or CGnull-repeats that were identified in Chapter 1, 
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the (CG)3 or CGnull-repeats in 6 HypoMDs were disrupted by inducing sequence 
insertions or deletions (indel mutations) in vivo using CRISPR-Cas9. Medaka embryos 
were injected with Cas9 mRNA and target-specific sgRNAs at 1-cell stage and allowed 
to develop to the blastula stage (2000–4000 cells; at approx. 8 hour-post-fertilization; 
see also Figure 2.1 for a schematic illustration of the experiment). The methylation state 
of the targeted HypoMDs was determined by bisulfite PCR, subcloning and Sanger 
sequencing. Alleles (i.e. individual sequencing reads) were filtered for the presence of 
indels in the targeted (CG)3 and CGnull-repeats, i.e. successful disruption. In spite of 
the strong statistical enrichment of (CG)3 and CGnull-repeat in HypoMDs as shown in 
Chapter 1, disruption of these motifs did not result in any alteration to the 
hypomethylated state of the targeted HypoMDs. In fact, all of these HypoMDs 
remained completely unmethylated (i.e. 0% methylation across all CpGs) after the 
CRISPR-Cas9-mediated disruption (Figure 2.2). These results suggest that either (1) 
DNA sequences were not perused until genome-wide reprogramming is required (e.g., 
in primordial germ cells and during gametogenesis), hence the effect of motif 
disruption could not be manifested, (2) the local hypomethyation state is redundantly 
conferred by unknown sequence pattern(s) in addition to (CG)3 or CGnull-repeats, or 
(3) the targeted sequence patterns are simply not related to the hypomethylated state, 
in spite of their strong statistical association. These possibilities were thoroughly tested 
in subsequent experiments as follows. 
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2.2.2 Methylation state of the (CG)3- or CGnull-repeat-disrupted HypoMDs 
remained unchanged in F1 blastula embryos 
To delineate whether the disruption of (CG)3 and CGnull-repeat could lead to 
alteration in local methylation state after genome-wide reprogramming, the CRISPR-
Cas9 injection experiment was repeated. The injected embryos were reared to adults 
(approx. 3 month-post-hatch) and genotyped to identify founder mutants, which were 
than inter-crossed to produce F1 generation that inherited the indel mutations through 
germline transmission. The methylation state of the edited loci was examined in F1 
embryos at the blastula stage. In spite of substantial amount of time was passed since 
the disruption of the (CG)3 and CGnull-repeat (> 3 months) and of the expected 
genome-wide reprogramming during primordial germ cells formation and 
gametogenesis in the F0 founders, as well as immediately after the fertilization of their 
gametes, the targeted HypoMDs remained completely unmethylated (methylation rate 
= 0% across all examined CpGs, as in Figure 2.2) in the F1 offspring.  
 
2.2.3 DNA methylation states are not autonomously determined by 
nucleotide sequence at ectopic genomic positions 
To address the possible redundancy of sequence determinants in HypoMDs and to gain 
genome-wide insight into the autonomy of methylation state determination by 
genomic sequence, medaka genomic DNA was fragmented, captured, then integrated 
back into the genome with or without prior artificial methylation. In brief (see Materials 
and Methods for details), medaka genomic DNA was digested and enriched for CpG-
containing fragments (40–220 bp; extended to 180–360 bp with adaptors) using a 
library preparation method identical to that was designed for reduced representation 
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bisulfite sequencing (RRBS) (Gu et al. 2011). The PCR-amplified (hence, unmethylated) 
fragments were labelled (methylation at the N6 position of the adenine in the Dam sites, 
5’-GATC-3’, inside the adapters), which is followed by (or without) artificial CpG 
methylation in vitro, then introduced into medaka zygotes and allowed for random 
genome integration via highly efficient I-SceI-mediated random genome integration 
(see Figure 2.3 for graphical procedures). Integration was expected to occur at 1-cell 
stage, immediately after injection (Thermes et al. 2002). The unintegrated fragments 
were then removed by size-selection and DpnI-digestion (see Materials and Methods 
for details and Figure 2.4 for removal efficiency). The methylation state of the integrated 
fragments was subsequently gauged at the blastula stage (2000–4000 cells) using 
bisulfite PCR and high-throughput sequencing. The assayed integrated fragments 
encompassed nearly the entire range of GC content and CpG density of HypoMDs and 
HyperMDs (Figure 2.5 vs Figure 1.2). Approximately equal number of CpGs from 
HypoMDs and HyperMDs were assayed (Figure 2.6). 
In spite of the strong statistical association between nucleotide sequence and 
methylation states as described in Chapter 1, the integrated genomic fragments could 
not recapitulate their endogenous methylation state at ectopic locations. The 
methylation rate at endogenous loci and that at ectopically integrated locations showed 
essentially zero statistical correlation: Spearman’s ρ ≤ 0.08, Kendall’s τ ≤ 0.07 (see 
Figure 2.7 for biplots). Without prior artificial methylation, CpGs on the integrated 
fragments were almost entirely unmethylated regardless of their endogenous state 
(Figure 2.8: upper-left vs lower-left). The lack of sequence dependency was further 
illustrated by a drastically different ectopic methylation pattern when the genomic 
fragments were artificially methylated prior to injection and genome integration 
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(Figure 2.7: panel A vs B; Figure 2.8: left vs right). The sharp contrast in the ectopic 
methylation patterns suggested that nucleotide sequence alone does not carry adequate 
information for the determination of its own methylation state. 
Notwithstanding, the artificially methylated, integrated fragments contained a 
substantial number of unmethylated CpGs when examined at the blastula stage (Figure 
2.8: the peaks at 0% in both upper- and lower-right panels). These unmethylated CpGs 
were unlikely due to incomplete artificial methylation prior to injection since: (1) the 
methylase (CpGs-specific DNA methyltransferase SssI, a.k.a. “M.SssI”) used is known 
to completely methylate CpGs in all sequence context (Fatemi 2005), and (2) evidently 
complete methylation was routinely achievable by the optimized reaction regimen (see 
Figure 2.9 for examples using bacterial genomic DNA and vector library that have 
higher CpG frequencies per unit weight of DNA than the medaka genome). The 
observed unmethylated CpGs could be caused by demethylation in the injected 
embryos. However, such demethylation could not be directly inferred as recapitulation 
of the endogenous methylation state, since there was an absence of correlation between 
the endogenous and ectopic states (Figure 2.7: panel B; Also see Figure 2.8: upper-right 
vs lower-right panels). In addition, the observed loss of premethylated state was 
unrelated to the endogenous chromatin accessibility (hence, potential binding of- or 
recognition by- transcription factors), as CpGs originated from heterochromatin and 
euchromatin were equally susceptible to the loss of methylation (right panels of Figure 
2.10; note the peaks at 0% methylation rate in the histograms along Y-axes). To clarify 
if the observed demethylation could be due to sequence features intrinsic to the 
integrated fragments, the nucleotide sequences (10 bp from both up- and down-stream) 
encompassing CpGs that were demethylated were compared with those that were 
 32 
maintained as hypermethylated using kmer-SVM with the same parameters as Chapter 
1. However, the resultant SVMs were highly imprecise and insensitive (Figure 2.11: area 
under precision-recall curve ≤ 0.47, versus 0.43 from random classifier; Matthew’s 
correlation coefficient ≤ 0.07). Also, the overall ectopic methylation states, as well as the 
demethylation, of the integrated fragments do not correlate with their size or CpG 
density (Figure 2.12). Together, the observed demethylated state could not be related to 
intrinsic sequence features of the genomic fragments. 
Given that the injected genomic fragments were (1) only partial fragments of 
HypoMDs or HyperMDs and may lack the presumed sequence features that are 
required for autonomous determination of methylation state, and (2) integrated into 
random genomic positions where they might be influenced by local chromatin state, it 
is logical to speculated that the observed demethylation might be due, at least in part, 
to the local epigenetic state of the integrated loci (i.e. position effect; E.g., integrated 
into pre-existing HypoMDs or somewhere under the influence of trans-acting 
hypomethylation determining elements, hence rendered hypomethylated). Further 
experiments were thus conducted at pre-specified genomic loci to control for the 
possible position effect. 
 
2.2.4 DNA methylation state was maintained independent of sequence and 
position context 
In order to examine whether  full-length HypoMDs and HyperMDs can autonomously 
determine their own methylation state at an inert genomic location, six unmethylated 
HyperMDs and eleven pre-methylated HypoMDs with length of 300–400 bp were 
randomly selected, cloned (with or without artificial CpG methylation), and injected 
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into one-cell stage medaka embryos and integrated into the gene desert region 
(Kirchmaier et al. 2013) presumably devoid of any possible influence of active 
regulatory elements (see also Figure 2.13A). The integration was achieved by the highly 
efficient, PhiC31 integrase-mediated site-specific integration in medaka and was 
expected to occur at the one-cell stage (Kirchmaier et al. 2013). Methylation state of the 
integrated sequences were examined at the blastula stage. Autonomy in methylation 
state determination by the full-length, integrated sequences would manifest as 
remethylation of the unmethylated HyperMDs, as well as active or passive loss of the 
methyl groups on the premethylated HypoMDs, after genome integration (see also 
Figure 2.13B for illustration of the logic of the experiment). 
All of the unmethylated, integrated HyperMDs failed to acquire methylation 
(Figure 2.14). Likewise, the artificially methylated, integrated HypoMDs remained 
hypermethylated (Figure 2.15), with very limited number of CpG dinucleotides (i.e. 
only 4 out of the 202 CpGs inspected) showing no methylation (Figure 2.15: blue dots 
on the integrated, ectopic copies of HypoMDs/Loci 1, 4, 6, and 9). Since the 
determination of methylation state of these distinct CpGs in the premethylated plasmid 
library is infeasible (as plasmid DNA converts very poorly in bisulfite reaction), it is 
possible that these CpGs were not fully methylated prior to injection. However, as 
aforementioned, the M.SssI methyltransferase used in the pretreatment has no known 
sequence specificity. The observed absence of methylation probably reflects highly 
localized loss of methyl groups on these specific CpGs. Collectively, the above results 
indicate that the overall, ectopically introduced nucleotide sequences were not perused 
and the artificially conferred methylation states (i.e. hypomethylation in the HyperMDs, 
and hypermethylation in the HypoMDs) were robustly maintained in vivo. 
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Finally, to ascertain that the above unexpected observations were not artifacts 
incurred by ectopic genome locations, the methylation state of two HypoMDs were 
edited in situ via CRISPR-Cas9-triggered homology-directed repair (HDR) and 
artificially methylated repair template (see Figure 2.16 for illustration of concept behind 
the experiment). Consistent with the aforementioned observations, in spite of their 
original hypomethylated state, the loci were rendered largely hypermethylated after 
editing (Figure 2.17). Since the observed lack of restoration of native methylation state 
could be due to the seemingly limited time allowed for recapitulation (from injection 
to sampling, i.e. from 1-cell stage to blastula: approx. 8 hr, encompassing 11-12 rounds 
of cell divisions), the editing experiment was repeated and the endpoint was extended 
to later developmental stages: Stage 31 and 39, at 3 and 7 day-post-fertilization (i.e. day-
post-injection), respectively. Yet, the edited alleles remained hypermethylated in the 
mid-/late-stage embryos (Figure 2.18). Significant loss of methyl groups could only be 
observed on two distinct, adjacent CpGs in one of the two edited loci (Figure 2.18, panel 
B: the 1st and 2nd CpG). Taken together, these observations indicate that genomic 
sequence and its methylation state were not coupled even at the endogenous position. 
 
2.3 Discussion 
The above experimental results definitely showed that local methylation state is not 
autonomously determined by nucleotide sequence in medaka in vivo, in spite of the 
strong statistical association between DNA methylation state and the underlying 
nucleotide sequence as reported in Chapter 1. The disruption of highly enriched DNA 
motifs (i.e. consecutive CGs and CGnull-repeat) in HypoMDs failed to obliterate the 
hypomethylated state in both F0 and F1 medaka embryos. Also, by artificially 
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manipulating the methylation state of native genomic sequences and reintegrating 
them into the medaka genome, the artificially conferred methylation states were shown 
predominantly maintained in vivo, regardless of the sequences and their endogenous 
states. These findings strongly argue against the general belief that the DNA 
methylation landscape in vertebrates is sequence-dependent. 
 These unexpected results are in clear contradiction to the recent in vitro studies 
as reviewed in this chapter’s Introduction. As aforementioned, those in vitro evidence 
is derived almost exclusively from mouse ESCs (Lienert et al. 2011; Stadler et al. 2011; 
Krebs et al. 2014), which are known to be epigenetically unstable and can thrive without 
DNA methylation unlike most other vertebrate cell types both in vitro and in vivo. Due 
to the atypical epigenetic characteristics of cultured mouse ESCs, whether and to what 
extent can those in vitro findings be extrapolated to an in vivo context remains 
unknown. 
On the contrary, the findings as presented in this chapter are coherent to the 
pioneer experiments (Pollack et al. 1980; Wigler 1981; Stein et al. 1982) on the 
inheritance of DNA methylation in cultured mouse L cells. In those reports, the authors 
demonstrated that the methylation states of exogenous DNA (regardless of being 
artificially CpG-methylated or completely unmethylated) could be maintained with 
appreciable fidelity for many cell generations upon stable integration. Taken together, 
the recently proclaimed sequence-dependency of DNA methylation is far from concrete. 
However, this study does not completely rule out the existence of highly confined, 
local sequence-dependent DNA methylation. As proposed by Richards (2006), the 
sequence-dependency of epigenetic signatures may vary with actual sequence-context, 
i.e. some nucleotide sequences may favour or even mandate a certain methylation state, 
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while others may be completely independent of DNA methylation. Although the 
artificially established hypermethylated state of the sequences examined in this study 
was mostly maintained after genome integration, there was complete loss of methyl 
groups on some CpGs in the eleven pre-methylated HypoMDs, as well as within one of 
the in situ edited loci. This suggests the presence of local sequence elements that 
facilitate demethylation on specific CpGs, although their effect was spatially confined. 
As previously demonstrated in vitro, some DNA motifs, in particular several 
transcription factor binding sites (Blattler and Farnham 2013), are indeed instructive 
to DNA methylation and may account for the change of methylation state in specific 
loci upon differentiation (Meissner et al. 2008; Hodges et al. 2011). Importantly, their 
effect was also demonstrated to be limited to no more than a few tens of base pairs up- 
and down-stream (Stadler et al. 2011; Krebs et al. 2014). It is thus likely that the 
restricted governing range (< 100 bp) of these DNA sequences is insufficient to account 
for the span of HypoMDs (median length > 1 kb). 
 
2.4 Chapter conclusion 
In spite of the observed statistical association (Chapter 1), nucleotide sequence was not 
capable of autonomously determining its own methylation state in medaka in vivo. The 
above experimental results clearly demonstrated that DNA methylation state was 
robustly maintained in vivo, independent of the underlying sequence and the 
endogenous state. This unexpected finding apparently contradicts the notion of the 
governance on DNA methylation by genomic sequence in vertebrates, but instead 
suggest the involvement of other epigenetic factors in defining and maintaining the 
DNA methylation landscape. 
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Figure 2.1    Schematic diagram illustrating the disruption of (CG)3 or CGnull-
repeat in a HypoMD via CRISPR-Cas9 and the expected outcomes depending 
on whether these sequence motifs are responsible for the local 
hypomethylated state. 
The (CG)3 or CGnull-repeat is represented by the blue box inside the targeted HypoMD 
(orange segment). The motif is disrupted by CRISPR-induced double-strand break and 
the subsequent indel (red cross) formed via non-homologus end-joining (NHEJ) or 
alternative non-homologous end joining (A-NHEJ, a.k.a. microhomology-mediated 
end joining / MMEJ). Major genome-wide de novo methylation (denoted by green stars) 
for the acquisition of zygotic DNA methylome is known to occur at some point between 
64-cell and blastula stage (Walter et al. 2002). Epigenetic reprogramming is expected to 
occur during primordial germ cell development (denoted by purple star) and 
gametogenesis (denoted by yellow star). The artistic drawings of adult medaka is a 
courtesy of Dr. Ayako Uno. 
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Figure 2.2    Methylation state of six HypoMDs after disruption of the (CG)3 (Locus 1-3) or CGnull-repeat (Locus 4-6) by the use of 
CRISPR-Cas9. 
Native methylation state was overlaid as reference. Pink crosses indicate the CRISPR-Cas9-induced indel locations. Note that the methylation rate 
is zero across all CpGs (i.e. completely unmethylated) with or without editing. Mean coverage = 5×.
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Figure 2.3    Schematic diagram illustrating the capturing and processing of 
genomic fragments for the interrogation of their autonomy in methylation 
state determination. 
The orange segment represents genomic region that is endogenously hypomethylated. 
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Figure 2.4    Efficient removal of injected but unintegrated libraries via PEG 
precipitation and DpnI digestion. 
(A) MspI-captured fragments with or without pre-methylation via CpG 
methyltransferase M.SssI. Since it is technically infeasible to prevent the spontaneous 
integration of linear DNA, an integration-free surrogate control (“2× spike-in”) was 
generated by spiking-in the injection mixtures directly into fresh lysate of uninjected 
blastula embryos. Approximately twice the amount of the injection mix consumed by 
genuinely injected embryos (“Injected”), i.e. ca. 34 pL per embryo, was spiked-in to 
provide conservative estimation of the removal efficiency of unintegrated fragments. 
(B) Plasmid libraries containing unmethylated HyperMDs or M.SssI-methylated 
HypoMDs. Since spontaneous integration of circular DNA (i.e. plasmids) into the 
genome is generally very rare in the absence of integrase, integration-free surrogate 
control (“- integrase”) was generated by injecting PhiC31 medaka embryos without 
PhiC31 integrase mRNA (in contrast to 100 ng/µL of the mRNA for the integration 
experiment, i.e. “+ integrase”). Error bars represent 95% confidence intervals. 
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Figure 2.5    Violin plots showing the distribution of (A) length, (B) GC content, and (C) CpG density of the unmethylated or pre-
methylated fragments that were successfully integrated into genome and subsequently assayed. 
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Figure 2.6    Sampling origins (from HypoMDs, HyperMDs, or elsewhere in the 
genome) of the assayed CpGs on the integrated genomic fragments. 
Note that CpGs from HypoMDs and HyperMDs were nearly equally represented 
(upper panels vs lower panels). 
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Figure 2.7    Correlation between the methylation rate of the same CpGs at their endogenous versus at reintegrated/ectopic positions, 
(A) without- or (B) with- artificial methylation prior to injection and genome integration. 
The methylation rates were bimodal and strongly skewed towards either 0% or 100%. To circumvent over-plotting, individual CpGs, N = (A) 10251 
and (B) 18537, were consolidated into hexes (bin width = 1%), with the shade of the hex representing the number of CpGs included (in logarithmic 
scale). Bars on the top and right-hand side of each of the scatterplots are the histograms that show the density of CpGs along the corresponding 
axes (bin width = 1%). Correlation coefficients: Spearman’s ρ = (A) 0.08, (B) 0.02; Kendall’s τ = (A) 0.07, (B) 0.01.
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Figure 2.8    Distributions of the methylation rates of CpGs on the integrated 
genomic fragments, (left) without- or (right) with- artificial methylation prior 
to injection. 
The distributions were displayed separately for CpGs that are endogenously (upper) 
hypomethylated and (lower) hypermethylated. Bin width = 1%. Note that the 
histograms in the upper panels (i.e. CpGs that are endogenously hypomethylated) 
strongly resemble those in the lower panels (i.e. CpGs that are endogenously 
hypermethylated). “N” denotes the number of CpGs included in the corresponding 
histogram. 
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Figure 2.9    Differential sensitivity of untreated and M.SssI-treated DNA 
samples to MspI and HpaII restriction enzymes. 
(A) E. coli genomic DNA. (B) Plasmid library that was used to generate results shown 
in Figure 2.15. Approximate CpG and MspI/HpaII restriction site densities (counts per 
kilobase pair): (A) 76 and 5, (B) 62 and 4, which are much higher than those in medaka 
genome, i.e. 23 and 1. Note that there is no observable cleavage by HpaII after 
pretreatment with the methyltransferase, suggesting complete methylation was 
achieved using the reaction regimen as described in Materials and Methods. “L”: 
Thermo Fisher Scientific 1Kb Plus DNA ladder. “Mock”: control reaction without 
restriction enzyme. 
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Figure 2.10    Correlation of CpG methylation state at ectopic versus native 
positions with respect to the endogenous local chromatin accessibility. 
CpGs from the inside and outside of DNaseI hypersensitive sites (DHS) were graphed 
separately (i.e. upper versus lower panels). To circumvent over-plotting, overlapping 
CpGs were consolidated into hexes (bin width = 1%), with the shade of the hex 
representing the number of fragments included (in logarithmic scale). Numerical 
figures denoted at the center of each of the biplots are the correlation coefficients. ρ = 
Spearman’s rho; τ = Kendall’s tau. 
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Figure 2.11    Model performance of kmer-SVMs trained for classification of CpGs and their flanking sequences that underwent 
demethylation. 
Demethylated (N = 23655) and hypermethylated (N = 30760) sequences (including 10 bp from both up- and down-stream of the CpG) were 
assigned to positive and negative classes, respectively. (A) Precision-recall curves. Solid, colored lines are individual precision-recall curves derived 
from 10-fold cross-validation. The colors represent the cut-off values for binary classification/prediction of the testing pool in each rounds of cross-
validation. Area-under-curve (AUC): minimum = 0.46, maximum = 0.47. Random classifier is represented by horizontal dashes at the center and 
has an AUC of 0.43. (B) Matthew’s correlation coefficients (MCC). Individual lines are the MCCs, with respect to all possible cutoff values, derived 
from 10-fold cross-validation. Maximum MCC achieved = 0.07. 
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Figure 2.12    Correlation between the overall methylation rate and (A) length or (B) CpG density of the integrated fragments. 
Integrated fragments derived from the (left) unmethylated and (right) M.SssI-treated libraries were further segregated according to 
their endogenous methylation state (top vs bottom). 
Fragments are defined as endogenously (top) hypomethylated or (bottom) hypermethylated if they have a mean CpG-methylation rate of < 40% 
or > 60%, respectively. To circumvent over-plotting, fragments with similar methylation rate and (A) length or (B) CpG density were consolidated 
into hexes (number of bins = 100, both horizontally and vertically), with the shade of the hex representing the number of fragments included (in 
logarithmic scale). “ρ” and “τ” indicate the Spearman’s rho and Kendall’s tau correlation coefficients of the corresponding scatterplots.
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Figure 2.13    Interrogation of DNA methylation recapitulation by full-length 
HyperMDs and HypoMDs at pre-specified, inert genomic location. 
(A) Genome browser view of methylation state (as in HdrR strain) of the genomic locus 
that contains a landing site for PhiC31-mediated site-specific recombination 
(approximate location is denoted by the purple triangle). (B) Schematic diagram 
illustrating the irreversible, site-specific integration of the subcloned, unmethylated 
HyperMDs and pre-methylated HypoMDs via PhiC31-integrase-mediated site-specific 
recombination and the expected outcomes depending on whether the integrated 
sequences can autonomously determine their own methylation state. 
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Figure 2.14    Methylation state of six full-length HyperMDs at their 
endogenous loci and at ectopic location after being cloned and integrated into 
genome via PhiC31-mediated site-specific recombination. 
Note that all of the integrated sequences failed to recapitulate their endogenous 
hypermethylated state. Mean coverage = 20×. 
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Figure 2.15    Methylation state of eleven full-length HypoMDs (Locus 1 to 11) 
at their endogenous loci and at ectopic location after being cloned, artificially 
methylated, then integrated into genome via PhiC31-mediated site-specific 
recombination. 
Note that all of the pre-methylated, integrated sequences failed to recapitulate their 
endogenous hypomethylated state. Complete loss of methylation was only observed in 
very small number of CpGs in three of the examined sequences: the 9th CpG of Locus 1, 
the 1st CpGs of Locus 4, the 1st CpG of Locus 6, and the 14th CpG of Locus 9. Mean 
coverage = 15×. 
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Figure 2.16    Schematic diagram illustrating the principle of the in vivo 
methylome editing on the targeted HypoMDs via homology-directed repair 
(HDR) and the use of artificially methylated repair template. 
HDR was triggered by CRISPR-Cas9 induced DNA double-strand breaks (DSB) at the 
targeted loci. The repair template contains the subcloned HypoMD (with substitutions 
in the spCas9’s PAM sites, from 5’-NGG-3’ to 5’-NGC-3’) along with approximately 
800 bp flanking regions that served as homology arms. Note that multiple DSBs was 
made using a cocktail of sgRNAs that guided spCas9 to six different positions along the 
targeted HypoMD to enhance DSB, hence HDR, rate. 
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Figure 2.17    Methylation state of two HypoMDs after in vivo methylome 
editing mediated by CRISPR-Cas9-induced homology-directed repair (HDR) 
and pre-methylated repair templates. 
Green arrowheads: bisulfite PCR and sequencing primers; red triangles: binding 
positions of the sgRNAs. 
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Figure 2.18    Methylation state of the in situ-edited HypoMDs at multiple 
embryonic stages. 
Edited embryos were sampled at early (blastula, 0 day-post-fertilization; dpf), mid (3 
dpf), and late (7 dpf; hatching) embryonic stages. To enable comparison across 
sampling time-points with variable editing efficiency, the estimated methylation rates 
were normalized against the estimated editing rate. 
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General discussion and perspectives 
Based almost exclusively on in silico and in vitro evidence, it is generally believed that 
the vertebrate genomes are hypermethylated “by default”, and that specific nucleotide 
sequence features (specifically, high CpG density and the presence of certain 
transcription factor binding sites) encode and autonomously determine the local 
hypomethylated state at specific loci. Since (1) nucleotide sequences do confer adequate 
complexity for specific regional recognition along the genome and (2) the genome is 
the only hereditary material that can be faithfully replicated and passed on to progenies, 
the surmised dependency between DNA methylation state and the underlying sequence 
features does provide the most parsimonious and logically appealing explanation to the 
precise patterning and inheritance of the DNA methylome in vertebrates. 
The results presented herein, however, definitively showed that, despite the 
strong statistical association (Chapter 1), there is no immediate connection between 
DNA methylation state and the underlying nucleotide sequence in vivo (Chapter 2). 
Importantly, disruption of the top enriched DNA motifs by the use of CRISPR-Cas9 
failed to induce any change to the methylation state of the targeted hypomethyated 
regions. Moreover, by manipulating and controlling the methylation state of the 
genomic fragments prior to reintegration into the genome, it is clearly demonstrated 
that the artificially granted methylation states were predominantly maintained in vivo, 
independent of the nucleotide sequences and their endogenous methylation states. 
More importantly, the artificially conferred methylation states appear to be stably 
maintained in the medaka embryos, independent of the native states. Such robustness 
is corroborated and further exemplified by a previous medaka transgenic study (Uno 
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2015) that the endogenously hypermethylated genomic sequences were found 
hypomethylated after subcloning (hence unmethylated) and stable genome 
reintegration as transgenes, and such hypomethylated state were faithfully cascaded to 
the F2 generation, i.e. from F0 to F2: across > 6 months and 3 animal generations. The 
faithful maintenance of artificially conferred methylation states is in contradiction to 
the aforementioned prevailing belief that the vertebrate genome is hypermethylated “by 
default” except for the loci that contain the supposed hypomethylation determinants. 
Thus, the experimental results presented herein not only disproved the inferred 
determining role of DNA sequence on the methylation landscape, but also defied the 
long-standing belief that there is a default state (i.e. hypermethylation) for vertebrate 
genomes. 
In fact, the postulated strict sequence-dependency is paradoxical to the concept 
of epigenetics itself. There are accumulating reports for the last two decades that DNA 
methylation could be perturbed by transient physiological stress or chemical exposure. 
More importantly, the perturbed states could be persistent and sometimes inheritable, 
while the underlying genomic sequence remains unchanged (Richards 2006; Bird 2007; 
Feil and Fraga 2012; Heard and Martienssen 2014). These observations highlighted that 
DNA methylation pattern is not directly coupled with the underlying genomic 
sequence in vivo, in spite of what has been repeatedly shown in silico and recently 
demonstrated in vitro. 
The proven lack of immediate sequence-dependency in DNA methylome in 
vivo might appear to contradict the widely observed statistical association between 
genomic sequence and its DNA methylation pattern. While it is true that statistical 
correlation/association does not necessarily imply a causal relationship, strong 
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statistical correspondence does often reflect the existence of direct or indirect 
relationship. Indeed, the correlation between methylation and nucleotide sequence 
pattern is well explainable. First, as is shown by the statistical modelling in Chapter 1, 
the precision and sensitivity of methylation state prediction and classification by 
nucleotide sequence (hence statistical association) rely substantially on the fact that 
hypomethylated regions tend to have higher CpG density than the hypermethylated 
regions. In fact, CpG density is well acknowledged to be one of the key in silico 
predictors of methylation state (Illingworth and Bird 2009). Yet, as explained in 
Chapter 1’s Discussion, the relative enrichment of CpGs in hypomethylated regions can 
be accounted for by the spontaneous deamination, hence mutation, of methylated 
cytosine into thymine in the rest of the genome during vertebrate evolution. Therefore, 
the observed statistical association is, in part, indicative of the mutagenic consequence 
of the global methylation of vertebrate genomes; Second, as described in General 
Introduction, hypomethylated regions usually encompass gene regulatory elements, 
where binding sites of transcriptional regulators reside. The observed statistical 
association may hence reflect general enrichment of these binding sites in functional 
gene regulatory regions. For instance, calmodulin-binding transcription activators 
(CAMTAs), a family of general transcription activators that regulates a broad range of 
genes, also have a core binding motif of CGCG (Finkler et al. 2007), which is highly 
enriched in medaka’s HypoMDs (see Chapter 1). Taken together, DNA methylation 
state and the underlying genomic sequence are conceivably related, albeit not 
necessarily in a causal relationship. 
While this study does argue against the notion that that the genome-wide DNA 
methylation landscape is autonomously and primarily determined by the genomic 
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sequence in vertebrates, the experimental results presented herein does not rule out the 
possibility that nucleotide sequence might serve as a secondary/companion element in 
patterning of DNA methylome. This hypothesis is corroborated by a preliminary study 
conducted by Fukushima et al. (personal communication) in Takeda’s laboratory, the 
University of Tokyo. In their experiment, they surveyed the methylation state of a 
transgene construct that comprises ~140 kb-long medaka genomic region (except with 
two open reading frames replaced by coding sequences of fluorescent proteins). The 
transgenic line of medaka that hosts this construct (Moriyama et al. 2012) had been 
curated for at least 4 years and 16 animal generations. The authors identified that the 
periphery of the transgene construct in the long-curated transgenic line did largely, 
albeit imperfectly, recapitulate the methylation pattern of its endogenous counterpart, 
whereas the centre of the construct remained poorly methylated, unlike the endogenous 
locus. The distinct difference in methylation state between the peripheral and the centre 
of the construct suggests that the recapitulation of DNA methylation pattern on ectopic 
sequence could be a progressive process that spans a timescale of years and/or require 
many rounds of epigenetic reprogramming (which is triggered in-between animal 
generations, i.e. during gametogenesis and fertilization). The authors’ observation also 
strongly indicates that local nucleotide sequence might serve as a guide that defines the 
ultimate DNA methylation pattern. Indeed, the possible secondary role of nucleotide 
sequence in DNA methylation patterning also implies possible mechanistic relationship 
between DNA sequence and methylation, which further help explain the strong 
statistical association between nucleotide sequence and DNA methylation state. 
Given that the nucleotide sequence itself is not sufficient to determine its own 
methylation state, the patterning of DNA methylation landscape must involve other 
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epigenetic factors as previously suggested by Kaminsky et al. (2009). Indeed, DNA 
sequences examined in Chapter 2, as well as in the aforementioned transgenic studies 
by Uno (2015) and Fukushima et al. (unpublished data), were all purified prior to being 
introduced into the genome, hence initially lacked any associated factor(s) that could 
participate in the determination/modulation of local DNA methylation. While the 
identity of these presumed determinants remains elusive, they are unlikely to be 
transcription factors as they could not be efficiently recruited onto the integrated DNA 
in a sequence-dependent manner within 6 months or 3 animal generations (Uno 2015). 
Nevertheless, it is beyond doubt that the identification for the genuine methylation 
determinant(s) is of utmost importance and urgently needed as this is imperative to the 
deciphering of the mechanism and logic behind DNA methylome establishment in vivo. 
The strong link between DNA methylation, nucleosome position, and histone 
modifications (Fuks 2005; Cedar and Bergman 2009; Chodavarapu et al. 2010) suggests 
that local chromatin state could be one of the ultimate governors of DNA methylation 
state. However, proving this postulation experimentally is currently technically 
infeasible as molecular tools for manipulation of nucleosomes and histone 
modifications in vivo are not yet available. It is currently known that (1) there are 15 
possible modifications (or 28 if the absence of functional group attachment is also 
considered as one form of ‘modification’) on 13 different amino acid residuals of the 4 
histones (i.e. H2A, H2B, H3, and H4) that constitute the nucleosome core, (2) many of 
these modifications can co-exist or vary within the same nucleosome, and (3) H2A can 
be replaced by H2A.X (which can also be modified on 2 different amino acid residuals) 
or H2A.Z in some genomic loci and/or under certain cellular conditions. The 
overwhelming number of combinations of different modifications on different 
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residuals of different histones is a formidable hurdle for identifying and proving which 
particular sets of modifications and variants are responsible for DNA methylation 
determination. Moreover, while there were a few recent in vitro endeavours in 
achieving site-specific alteration of histone states by the use of dCas9-tethered histone 
modifiers (Kearns et al. 2015; Zentner and Henikoff 2015; O’Geen et al. 2017), their 
usability in an in vivo context remains unproven. In fact, similar tools for the 
manipulation of most of the histone modifications and variants are not yet available 
nor currently conceivable both in vitro and in vivo, since many histone modifiers are 
associated with large multiprotein complexes (Bannister and Kouzarides 2011) that 
complicates construction of fusion proteins for tethering. Above all, unlike DNA 
methylation, how nucleosome and histone modifications are inherited across cell 
divisions remains poorly known. Further investigation into the mechanism of their 
deposition onto specific locations of the genome, and of their inheritance across cell 
division and animal generations is very much needed before they can be mechanistically 
related to the patterning of DNA methylome. 
 To conclude, this study strongly argues against the recent proposition that 
genome-wide DNA methylation pattern is primarily and autonomously determined by 
the underlying genomic sequence in vertebrates in vivo, but instead provides insights 
into potential involvement of other epigenetic factor(s) in defining the DNA 
methylation landscape. The data presented herein demonstrate that the DNA 
methylation landscape and genomic sequence are not directly coupled, which underpin 
the widely-observed plasticity of DNA methylation along differentiation, as well as the 
transgenerational inheritance of perturbed DNA methylation in vivo. However, it is 
worth noting that vertebrates could have variable DNA methylation dynamics, 
 61 
particularly during early embryonic development. This is true even within the same 
clade of vertebrate species (e.g., in mammals, the genome-wide methylation erasure 
immediately after fertilization is highly extensive in mice and human but very subtle or 
virtually absent from sheep; Young and Beaujean 2004). Further investigation in other 
vertebrate models will definitely be needed before generalization of the current 
observations made in medaka. 
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Materials and Methods 
HypoMD and HyperMD calling 
Published whole genome bisulfite sequencing reads of medaka blastula embryos (Qu et 
al. 2012) were fetched from the Data Bank of Japan (Accession number: SRX149583). 
Individual reads were trimmed to remove primers, adapters sequences, and low quality 
basecalls (Phred score ≤ 3) using BBDuk from the BBTools (Bushnell) ver. 35.85. 
Trimmed reads were mapped to the latest (as of the time of this writing) medaka 
genome assembly ver. 2.2.4 (all genome coordinates reported herein refer to this 
assembly version) using bwa-meth ver. 0.2.0. Methylation rates of the mapped CpG 
dyads were then extracted using MethylDackel ver. 0.2.1 with the default quality filters 
of MAPQ score ≥ 10 and Phred score ≥ 5. Only those CpG dinucleotides with at least 
5× coverage were considered as valid calls (Qu et al. 2012) and the final mean coverage 
after filtering was 8×. The same filtering criteria were also applied to all experiments 
throughout this study, wherever they are applicable. The endogenous methylation 
states of sequences assayed in this study were directly extracted from this mapped, 
filtered dataset. 
HypoMDs calling followed the same definition as previously published 
(Nakamura et al. 2014; Uno et al. 2016). Specifically, any stretch of ten or more 
hypomethylated (methylation rate < 40%) CpGs with no more than 4 interleaving non-
hypomethylated (methylation rate ≥ 40%) or undetermined (unsampled, unmappable 
or low coverage) dyads were called as HypoMD. HyperMDs were analogously defined 
as any stretch of at least ten hypermethylated (methylation rate > 60%) CpG dyads 
containing no more than 4 interleaving non-hypermethylated (methylation rate ≤ 60%) 
 63 
or undetermined CpGs. Length, GC content and CpG density of the called HypoMDs 
and HyperMDs were summarized in Figure 1.2. 
 
Supervised classification of HypoMD and HyperMD using support vector 
machine 
To elucidate whether HypoMDs and HyperMDs contain distinct sequence features, 
genomic sequences of all called HypoMDs (N = 18435) and HyperMDs (N = 231516) 
were subjected to supervised classification using kmer-SVM (support vector machine 
with string-, i.e. nucleotide sequences-, based spectrum kernel) (Fletez-Brant et al. 
2013). The default, recommended parameters and k = 6 (i.e. 6-mer) were used. 
Proportionally higher weights were assigned to HypoMDs (weight = 231516 ÷ 18435 = 
12.56) than HyperMDs (weight = 1) to offset the imbalanced sample sizes. Classification 
performance was gauged by 10-fold cross-validation and the area under precision-recall 
curves, as well as Matthew’s correlation coefficient. In parallel, the possible 
confounding effect of differential CpG density between HypoMDs and HyperMDs was 
controlled for by masking all CpG dinucleotides (i.e. from ‘CG’ to ‘NN’) and the SVM 
model was retraining using the same parameters as listed above. 
 
In vivo disruption of (CG)3 and ACGT-repeat in HypoMDs 
A total of 6 HypoMDs that contain a single (CG)3 or CGnull-repeat immediately 
followed by spCas9’s PAM (i.e. “NGG”) were randomly selected for targeted disruption. 
spCas9 mRNA was produced from pMLM3613 (a gift from Keith Joung; Addgene 
plasmid #42251) via in vitro transcription. sgRNAs were manually designed to target 
the 18-nt immediately upstream of the PAM site. spCas9 mRNA and sgRNA were in 
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vitro transcribed and purified as described in the section “General procedure: In vitro 
transcription for the generation of mRNA and sgRNA” below. spCas9 mRNA and sgRNA 
were co-injected (final concentration: 100 and 10 ng/µL, respectively, along with 0.05% 
phenol red) into drR medaka embryos at 1-cell stage. Approximately 200 embryos were 
injected with each sgRNA. The injected embryos were reared at 28oC to blastula stage 
(approx. 8 hours). Normally developed embryos (approx. 90%) were homogenized for 
genomic DNA extraction (see “General procedure: Genomic DNA extraction from 
medaka blastula embryos” below). The purified genomic DNA was bisulfite converted 
using MethylEasy Xceed Rapid DNA Bisulphite Modification Kit (Human Genetic 
Signatures, Australia) following manufacturer’s instructions, except that the DNA was 
denatured at 42oC for 20 mins. The targeted loci were PCR-amplified using target-
specific bisulfite PCR (BSP) primers designed in MethPrimer (Li and Dahiya 2002), 
TA-cloned using TOPO TA Cloning Kit, Dual Promoter (Thermo Fisher Scientific, 
USA) and transformed into E. coli, which were spread on lysogeny broth (LB) agar plate 
with ampicillin (50 µg/µL) to obtain single colonies. Individual colonies were randomly 
picked and expanded in LB with ampicillin (50 µg/µL). Plasmid from each of the 
expanded clones was extracted using QIAprep Miniprep Kit (Qiagen, USA) with the 
silica columns substituted by EconoSpin mini spin column (Epoch Life Science Inc., 
USA), then Sanger sequenced in ABI PRISM 3100 Genetic Analyzer using the BigDye 
3.1 chemistry (ThermoFisher Scientific). Sequences containing indels at the sgRNA-
target sites were selected and aligned to reference genomic sequence using MAFFT 
version 7. Methylation rate of CpGs within the target loci was manually enumerated 
(unmethylated C becomes T, while methylated C remains as C, after bisulfite PCR). 
 65 
 To obtain F1 generation that inherits disrupted (CG)3 or CGnull-repeat in the 
HypoMDs, the injection experiment was repeated and the injected embryo were reared 
to adulthood (i.e. for approx. 3 months). The adult fish were genotyped (see “General 
procedure: Genotyping” below). Five pairs of male and female fish with indel mutation 
at the targeted locus were intercrossed to produce F1 offsprings. The F1 embryos were 
allowed to develop to blastula stage, then homogenized and extracted for genomic DNA, 
which was bisulfite converted, PCR amplified to obtain methylation state of the target 
loci as aforementioned.  
 
In silico motif analysis 
The canonical 6-mers with positive weights (i.e. relatively enriched HypoMDs) and 
screened for those containing consecutive CpG (i.e. CGCG), along those that constitute 
CGnull-repeats (i.e. AGCTAG, GCTAGC, TAGCTA), were matched against the 
‘Vertebrates (in vivo and in silico)‘ databases in TomTom ver. 4.11.4 (Gupta et al. 2007). 
Only matches with false discovery rate < 0.1 were retained and reported. 
 
High-throughput transplantation of CpG-rich genomic loci 
To ascertain whether nucleotide sequences can autonomously determine their own 
methylation state in vivo at genome-wide scale, CpG-rich genomic fragments were 
captured and injected into medaka zygotes for random reintegration into the genome, 
then fished out to check for their methylation state. The capturing method was akin to 
those described for reduced representation bisulfite sequencing (RRBS). In fact, 
procedures up to the size selection of adaptor-ligated genomic fragments closely 
followed those optimized for RRBS (Gu et al. 2011). 
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In details, to obtain bulk genomic DNA for library preparation, adult medaka 
(drR strain; ca. 14-month-old) was anesthetized in ice-cold water and decapitated. 
Muscles were scraped from the tail using a scalpel. The muscles were ground to slurry 
in approx. 500 µL of lysis buffer (100 mM Tris-HCl, 50 mM EDTA, and 1% SDS). The 
slurry was incubated with 100 µg/mL proteinase K (Sigma-Alrich, USA) at 56oC for two 
hours with occasional, gentle mixing, cooled to room temperature and extracted with 
equal volume of Tris-saturated phenol-chloroform (pH 8) followed by chloroform 
extraction. Nucleic acids were precipitated by the addition of 0.6× volume of 
isopropanol and pelleted at 17900×g for 15 mins, desalted by washing with 70% ethanol, 
air-dried, then re-dissolved in 50 µL TE buffer. RNAs were degraded with 10 µg/mL 
RNase A (Wako Pure Chemical Industries, Japan) at 37oC for 1 hour. Proteinase K 
digestion, organic extraction, and isopropanol precipitation were repeated to remove 
the RNase and most of the degraded RNA. The resultant nucleic acid pellet was 
redissolved in 50 µL of 10 mM Tris-HCl, pH 8.0 and quantitated using Nanodrop 2000 
(Thermo Fisher Scientific). Approximately 20 ng of the extracted DNA was pre-stained 
with 1:600 GelRed (Biotium, USA) and eletrophoresized in 1% agarose gel, 0.5X TAE 
buffer for 1 hour to check for integrity. 
For fragmentation and capturing, 1 µg of the genomic DNA was digested with 
20 units of MspI (New England BioLabs, USA; a.k.a. NEB) in 50 µL of 1× NEB Buffer 2 
at 37oC overnight. Two µL of the digestion product were electrophoresized in 1% 
agarose gel (0.5× TAE) to ensure complete digestion. The digestion product was 
cleaned up via phenol-chloroform extraction, ethanol precipitated and re-dissolved in 
10 mM Tris-HCl, pH 8. End-filling and dA-tailing of the digestion product were carried 
out simultaneously: 300 ng of MspI-digested genomic fragments were incubated with 
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5 units of Klenow fragments (3'→5' exo-) and dNTP mix (10 mM dATP, 1 mM dCTP, 
and 1 mM dGTP) in 20 µL of 1× NEB Buffer 2 at 30oC for 20 mins, then at 37oC for 
another 20 mins. The product was purified via phenol-chloroform extraction and 
ethanol precipitation and were re-dissolved in 15 µL of 10 mM Tris-HCl, pH 8. The 
purified product was ligated to 0.75 µM of custom-made adapters using 2000 units of 
T4 DNA ligase (NEB) in 20 µL of 1× NEB T4 ligation buffer at 16oC overnight. The 
adaptor was prepared immediately before ligation by annealing 1 µL each of F3-02top 
and F3-02bottom (Appendix: Table 3) (synthesized by Thermo Fisher Scientific) in 10 
µL of annealing buffer (10 mM Tris-HCl, pH8, 50 mM NaCl, and 1 mM EDTA) via 
denaturation at 95oC for 2 mins and ramping down to 25oC at a rate of -0.1oC/second 
in a PCR machine. Ligation product was electrophoresized in parallel with the 20 bp 
DNA ladder (Takara Bio, Japan) in 3% agarose gel, 0.5× TBE buffer at 100V for 2 hours. 
The gel was post-stained in 3× GelGreen (Biotium) in 0.5× TBE buffer. The gel lane 
containing the fragments was excised for 160-340 bp dsDNA equivalent (corresponds 
to 40-220 bp adaptor-ligation fragments due to the Y-shaped adaptor that retards the 
molecules’ mobility in gel). Fragments were extracted from the excised gel and purified 
using Zymoclean Gel DNA Recovery Kit (Zymo Research, USA) according 
manufacturer’s instructions, except that 500 ng of sheared salmon sperm DNA were 
spiked into the dissolved gel prior to column loading to minimize sample loss during 
washing. Purified DNA was eluted in 20 µL 10 mM Tris-HCl, pH 8 into low-binding 
microfuge tube (Eppendorf, Germany). 
Adaptor-ligated fragments were enriched and amplified by PCR: 0.5 µL of 
eluted product, 200 µM dNTP, 300 nM each of F3-03F and F3-03R primers (containing, 
from 5’ to 3’ in this order, non-template I-SceI restriction sites, bisulfite PCR primer 
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F3-01 sites, and Dam site), and 10 units of PfuTurbo Cx polymerase in 200 µL (split 
into 8 tubes of 25 µL) of 1× PfuTurbo Cx reaction buffer (Agilent, USA) at 95oC 2 mins, 
18 cycles of 95oC for 30 s, 65oC for 30s, and 72oC for 45 s, then followed by 72oC for 5 
mins, finally held at 10oC until further processing. PCR product were pooled and 
purified with 1.8× volume of homemade SPRI magnetic beads (1:50-diluted 
carboxylated Sera-Mag Magnetic SpeedBeads in the SPRI buffer mix described below) 
(GE Healthcare, USA) and eluted in 42.5 µL of 10 mM Tris-HCl, pH 8. Two and a half 
microliters of the purified product were run in 3% agarose gel, 0.5× TBE buffer to check 
for properly selected sizes. Negative control was processed in parallel using identical 
procedures, except MspI was replaced with Milli-Q water in the beginning, and resulted 
in no amplification product. 
The amplified fragments were then Dam-methylated by incubating with Dam 
methylase to facilitate downstream counter-selection of unintegrated fragments. In 
details, the captured, amplified genomic fragments have two Dam sites (5’-GATC-3’) 
on the ligated adapters (one on each end; downstream of the BSP primer binding sites). 
The enriched CpG-rich fragments was tagged on the Dam sites via Dam methylation 
using 8 units of dam methyltransferase in 50 µL of 1× dam Methyltransferase Reaction 
Buffer (New England Biolabs) at 37oC overnight. Reaction product was ethanol 
precipitated, re-dissolved and re-incubated with fresh dam methyltransferase reaction 
mix overnight. Dam-methylated products were purified via phenol-chloroform 
extraction and ethanol precipitation, then re-dissolved in 20 µL of 10 mM Tris-HCl, pH 
8. One microliter of the purified product was used for photometric quantification using 
Nanodrop 2000 (Thermo Fisher Scientific). Nine microliters were aliquoted for 
injection and the rest was subjected to artificial CpG methylation as follows. 
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CpG methylation of the DNA fragments in vitro was mediated by CpG 
methyltransferase M.SssI: 10 µL of Dam-methylated fragments were incubated with 4 
units of M.SssI methyltransferase, 640 nM of fresh S-adenosylmethionine (a.k.a. SAM) 
in 50 µL of 1× NEB Buffer 2 at 37oC overnight. Reaction product was ethanol 
precipitated, re-dissolved and re-incubated overnight in the same volume of fresh 
M.SssI methyltransferase reaction mix, then purified via phenol-chloroform extraction 
and ethanol precipitation, finally re-dissolved in 10 µL of 10 mM Tris-HCl, pH 8. The 
purified product was quantitated using Nanodrop as above. All ethanol precipitation 
described above was carried out with spike-in of 1 µL of Ethachinmate (long, linear 
acrylamidic polymer) (Nippon Gene, Japan) as carrier to maximize DNA recovery. 
Immediately prior to injection, the methylated fragments (final concentration: 
10 ng/µL) were pre-treated with 5 units of I-SceI meganuclease in 20 µL of 1× I-SceI 
digestion buffer (New England Biolabs) at room temperature for 1 hour. Medaka 
zygotes were injected with Dam-methylated or Dam+CpG-methylated fragments at 1-
cell stage following standard procedures (Kinoshita et al. 2009). Around 500 embryos 
were injected with each pools of fragments and were allowed to develop to the blastula 
stage, i.e. Stage 11 by Iwamatsu (2004), at 28oC. The embryos were visually inspected 
under dissecting microscope with dead or malformed embryos discarded. Ultimately, 
496 (86%) and 433 (92%) embryos injected with Dam-methylated and Dam&CpG-
methylated fragments, respectively, developed normally to the blastula stage, and from 
which genomic DNA with fragments integrated was extracted (see “General procedure: 
Genomic DNA extraction from medaka blastula embryos” below). While most of the 
unintegrated fragments were presumably removed using our optimized DNA 
extraction method that includes size selection by PEG precipitation, carryover was 
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further minimized by incubating the extracted DNA with 2 µL of FastDigest DpnI 
(Thermo Fisher Scientific) in a 20 µL reaction volume for a total of 72 hours at 37oC in 
an incubator. This was followed by routine phenol-chloroform extraction and 
isopropanol precipitation. The precipitated DNA was finally re-dissolved in 20 µL of 
freshly dispensed Milli-Q water (Merck Millipore, USA). 
Efficient removal of unintegrated fragments was indicated by the parallel use of 
uninjected, spike-in control. Approximately twice the amount of the injection cocktail 
was spiked into the lysate of uninjected blastula embryos, which was then processed as 
described above. Relative quantity of library with or without integration was gauged by 
real-time PCR (THUNDERBIRD SYBR qPCR Master Mix, TOYOBO, Japan; in Agilent 
Stratagene Mx3000P, USA) using the library-specific primers F3-01F and F3-01R. In 
parallel, input DNA was also quantitated using primers F3-04F and F3-04R. 
Amplification plots were imported into qpcR v1.4.0 (Ritz and Spiess 2008), where the 
relative quantities were enumerated after sigmoidal modelling (all adjusted R2 = 1.00). 
The purified genomic DNA was then bisulfite-converted as described above. 
Integrated fragments were enriched via PCR using BSP primers F3-01F and F3-01R. 
The BSP products were dA-tailed and ligated to Illumina TruSeq adapters, pooled, and 
sequenced using Illumina MiSeq system. In detail, the integrated fragments were 
enriched from the bisulfite converted genomic DNA by PCR amplification using two 
high fidelity polymerases, ExTaq (Takara Bio) and KAPA HiFi Uracil+ (Kapa 
Biosystems, USA) separately. The BSP primers were originally designed and optimized 
for the use in ExTaq reaction. However, KAPA HiFi Uracil+ was also included for its 
low amplification bias and serve as a cross-reference to the ExTaq library. For ExTaq 
reaction: 2 µL of bisulfite converted genomic DNA was used as template in 50 µL of 
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ExTaq reaction with the primers F3-01F and F3-01R (500 nM each) at 95oC for 2 mins, 
35 cycles of 95oC for 30 s, 60oC for 30 s, 72oC for 30 s, then 72oC for 10 mins, and finally 
hold at 10oC until further processing; For Kapa HiFi Uracil+ reaction: 2 µL of bisulfite 
converted genomic DNA was used as template in 50 µL of KAPA HiFi HotStart Uracil+ 
ReadyMix (Kapa Biosystems, USA) reaction with the same primers (300 nM each) at 
95oC for 3 mins, 35 cycles of 98oC for 20 s, 60oC for 15 s, 72oC for 15 s, then 72oC for 30 
s, and finally hold at 10oC until further processing. PCR products were purified using 
1.8× volume of homemade SPRI beads and eluted in 10 µL of 10 mM Tris-HCl, pH 8. 
Yield was measured via fluorometric quantification using Qubit dsDNA HS Assay Kit 
and Qubit 2.0 Fluorometer (Thermo Fisher Scientific). The remaining eluates (405 ng 
and 423 ng from embryos injected with Dam-methylated or Dam&CpG-methylated 
fragments, respectively) were ligated with FastGene Adapter Kit for Illumina (Nippon 
Genetics, Japan) using KAPA Hyper Prep Kit (Kapa Biosystems) according to 
manufacturer’s instructions. No post-ligation library amplification was performed. 
Routine quality check was carried out using High Sensitivity DNA Kit on the 2100 
Bioanalyzer (Agilent, USA). Quantitation of the adaptor-ligated library was 
accomplished using GenNext NGS Library Quantification Kit (TOYOBO, Japan) in 
Mx3005P qPCR System (Agilent). Libraries were pooled in equal molar amount, 
denatured and diluted to a final concentration of ca. 13 pM with 20% PhiX control 
spiked-in for sequencing (MiSeq Reagent Kit v2; Illumina, USA). The automated 
sequencing run was conducted in paired-end mode (150 bp from each ends). A cluster 
density of ca. 1200/mm2 was achieved with over 85% of Phred score > 30. Sequencing 
outputs were minimally trimmed, mapped to genome, and called for methylation rate 
as aforementioned, except bwa-mem’s “-U” switch was set to its default. 
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In order to relate the methylation state of the integrated fragments to possible 
binding or recognition by DNA-binding proteins (e.g., transcription factors), DNase I 
hypersensitive sites (DHS) were identified by remapping the publicly available DNase-
seq dataset of drR medaka blastula embryos (accession number: SRX1032807) 
(Nakamura et al. 2017) to the medaka genome assembly v2.2.4. Adaptor trimming and 
alignment was accomplished using BBmap v37.36 (Bushnell) with default parameters. 
Aligned reads were filtered for a minimum MAPQ of 20. MACS v2.1.1.20160309 
(Zhang et al. 2008) was subsequently used to called 112987 peaks (DHS) with the 
following switches: “-g 6.3e+8 --nomodel --shift -50 --extsize 100 -q 0.01”. Vast 
majority (> 96%) of the assayed fragments were originated completely from either 
inside or outside, but not spanning across the boundaries, of DHS (Appendix: Table 5). 
 
Transplantation of Hypo-/Hyper-MDs to specific genomic locus via site-
specific recombination 
An engineered transgenic line that carries an attP site inside a gene desert on 
chromosome 18 for PhiC31 integrase-mediated recombination was used for site-
specific integration of the full-length, unmethylated HyperMDs (i.e. PCR-amplified, 
cloned, and without pretreating with M.SssI) and pre-methylated HypoMDs (i.e. PCR-
amplified, cloned, and pretreated with M.SssI) with lengths of 300–400 bp. 
PhiC31 integrase coding sequence was amplified from pPGK-PhiC31o-bpA (a 
gift from Philippe Soriano; Addgene plasmid #13795) and attached to SV40 nuclear 
localization sequence (NLS) using primer pair F4-01 and Phusion polymerase (Thermo 
Fisher Scientific), then blunt-end-cloned using Zero Blunt PCR Cloning Kit (Thermo 
Fisher Scientific). Cloning direction and proper coding sequence were checked via 
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Sanger sequencing (by FASMAC Co). PhiC31 integrase mRNA was generated from the 
constructed template via in vitro transcription (see “General procedure: In vitro 
transcription for the generation of mRNA and sgRNA” below). 
Six HyperMDs (see Appendix: Table 4) with flanking BSP primer binding sites 
(for F3-01F and F3-01R) and Dam-sites (downstream of the BSP primer sites) were 
directly synthesized by Thermo Fisher Scientific and Integrated DNA Technologies 
(USA) as double-stranded DNA and cloned into the targeting vector pEx_MCS-
attBtagRFPt (a gift from Joachim Wittbrodt; Addgene plasmid #48876). Eleven 
HypoMDs were amplified from drR genomic DNA and extended to include BSP primer 
binding sites and Dam-sites on both ends using primer sets primer sets F4-02 through 
F4-12, then cloned into the targeting vector. HyperMD-containing targeting vectors 
were propagated in dam+ E. coli (DH5α) (Thermo Fisher Scientific), pooled in 
approximately equimolar amount. HypoMD-containing targeting vectors were 
similarly processed, except that the pooled library was further artificially methylated 
with CpG methyltransferase M.SssI and purified as aforementioned. Individual plasmid 
libraries (final concentration: 10 ng/µL) was injected with PhiC31 integrase mRNA (100 
ng/µL) into >200 embryos of PhiC31 transgenic strain (Kirchmaier et al. 2013) at 1-cell 
stage. Injected embryos were reared at 28oC to blastula stage, screened for normal 
development (> 85%), homogenized, and extracted for genomic DNA (see “General 
procedure: Genomic DNA extraction from medaka blastula embryos” below). The 
extracted DNA was digested with DpnI to degrade unintegrated vectors, re-purified, 
bisulfite-converted, subjected to PCR via ExTaq polymerase, TA-cloned, Sanger 
sequenced, and quantified for methylation rate as aforementioned. 
 74 
To ensure the injected but unintegrated vectors were efficiently removed, the 
above injection was also carried out without PhiC31 integrase mRNA. These injected 
embryos were processed in parallel with those injected with integrase mRNA up to 
DpnI digestion. The relative abundance of undigested libraries (both unintegrated and 
integrated) was quantified and normalized to amount of input genomic DNA using 
real-time PCR as described above (Figure 2.4, panel B). 
 
In vivo ‘methylome editing’ via homology-directed repair 
Homology-directed repair was triggered by CRISPR-Cas9-induced double-strand 
breaks. spCas9 mRNA was produced from pMLM3613 (a gift from Keith Joung; 
Addgene plasmid #42251) via in vitro transcription. The HypoMDs, chr17:6415960–
6416269 (Locus 1) and chr21:25260707–25262742 (Locus 2), were randomly chosen as 
targets for editing. sgRNAs targeting these regions were designed using CCTop 
(Stemmer et al. 2015). The 6 top-ranked guide sequence designs (sets F5-01 and F5-02, 
for Locus 1 and 2, respectively) were synthesized (Thermo Fisher Scientific) and in vitro 
transcribed (see “General procedure: In vitro transcription for the generation of mRNA 
and sgRNA” below). To construct the repair template, these genomic regions (with 6 
mutations to the targeted spCas9 PAMs, i.e. from ‘NGG’ to ‘NGC’, in order to protect 
the template from being cleaved by spCas9) along with their up- and down-stream 
sequences (800 bp on both sides) as homology arms were synthesized by Integrated 
DNA Technologies (USA), assembled, cloned into pCR-BluntII vector (Thermo Fisher 
Scientific) using NEBuilder assembly mix (New England Biolabs) and propagated by 
dam+ E. coli. The repair templates were artificially methylated in vitro using CpG 
methyltransferase M.SssI and purified as described above. For each of the target regions, 
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sgRNA cocktail, spCas9 mRNA, and artificially Dam&CpG-methylated repair template 
were co-injected into approx. 200 medaka (drR strain) embryos at 1-cell stage at high 
concentrations (25 ng/µL each, 600 ng/µL and 10 ng/µL, respectively, i.e. 750 ng/µL of 
RNA and 10 ng/µL DNA in total) to maximize editing rate. Injected embryos were 
reared at 28oC for approx. 8 hours to blastula stage, screened for normal development 
(> 75%) and extracted for genomic DNA, which was DpnI-treated to degrade the repair 
template, re-purified, and bisulfite-converted as aforementioned. The BSP primer pairs 
(F5-03 and F5-04 for Locus 1 and 2, respectively) were designed using MethPrimer 2.0 
and screened for the presence of Dam-site (5’-GATC-3’) within the target range. The 
amplification products were Sanger sequenced from both ends. The methylation rate 
of each CpG was estimated from the sequencing chromatograms as: C ÷ (C + T) × 100%, 
where C and T are the called peak height in the ‘cytosine’ (i.e. methylated cytosines, 
after bisulfite PCR) and ‘thymine’ (i.e. unmethylated cytosines, which were converted 
to uracil by bisulfite treatment, then to thymine by PCR) channels, respectively. The 
signal intensities were extracted in R v3.3.3 (https://www.r-project.org/) using the 
sangerseqR package v1.12.0 (Hill et al. 2014). 
 To estimate the editing rate, regions containing the sgRNA target sites was PCR-
amplified from unconverted DNA using primer sets F5-05 through F5-09. Editing rate 
was gauged by the relative frequency of mutated sgRNA PAMs (5’-NGC-3’; on the 
edited alleles) versus the native PAMs (5’-NGG-3’; i.e. unedited alleles) from the Sanger 
sequencing trace using the same approach as described above. Editing efficiency was 
estimated to be 92.04% and 85.10% for Locus 1 and 2, respectively. 
To collect edited embryos at later developmental stages (3 and 7 day-post-
fertilization; dpf), the above cocktail was diluted 10-fold (in Milli-Q water; Merck 
 76 
Millipore) immediately prior to injection to reduce the toxicity (manifested after 
gastrulation) of ultra-high nuclei acid concentration at the expense of efficient editing. 
DNA extraction and subsequent processing were carried as above. Estimated editing 
efficiency for Locus 1 = 9.56% (at 3 dpf) and 7.81% (at 7 dpf); Locus 2 = 27.16% (at 3 
dpf) and 18.69% (at 7 dpf). In order to enable comparison across sampling time-points 
with variable editing rates, the estimated methylation rates were normalized to the 
editing efficiency (i.e. “normalized methylation rate” = “methylation rate” ÷ “editing 
rate”). 
 
General procedure: In vitro transcription for the generation of mRNA and 
sgRNA 
To produce mRNA for injection, the in vitro transcription template was amplified from 
the vector (using available standard sequencing primers other than T7 or SP6 promoter) 
and gel purified using Zymoclean Gel DNA Recovery Kit (Zymo Research). In vitro 
transcription and polyA-tailing were carried out using HiScribe ARCA mRNA Kit 
(NEB) according to manufacturer’s instructions, except that the T7 enzyme mix was 
replaced by SP6 polymerase mix (Thermo Fisher Scientific) if the template was to be 
transcribed from the SP6 promoter. Capped, polyA-tailed synthetic mRNA was 
purified using RNeasy Mini Kit (Qiagen, USA); sgRNAs for CRISPR-Cas9 were 
produced using EnGen sgRNA Synthesis Kit, S. pyogenes (NEB) following the supplied 
protocol. In vitro transcribed RNAs were purified via RNA Clean & Concentrator-5 
(Zymo Research). For in vivo methylome editing, 6 sgRNAs designed for the same locus 
were pooled in equal molar amount, ethanol precipitated, and re-dissolved in freshly 
dispensed Milli-Q water (Merck Millipore). Purified RNAs were all quantitated using 
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Nanodrop 2000 (Thermo Fisher Scientific). Approx. 100 ng of the RNA was 
electrophoresized in 1% agarose gel, 0.5× TAE (i.e. under native condition) to check for 
integrity. 
 
General procedure: Genomic DNA extraction from medaka blastula 
embryos 
Up to 20 blastula embryos were dispensed into individual 1.5 mL microfuge tubes and 
were homogenized in 200 µL of 2× CTAB extraction buffer containing 2% CTAB 
(cetrimonium bromide) (Wako Pure Chemical Industries, Japan), 100 mM Tris-HCl 
(pH 8), 20 mM EDTA, and 1.4 M NaCl, supplemented with 100 µg/mL of proteinase K, 
and incubated at 65oC overnight. The product was extracted with an equal volume of 
chloroform. Up to four aqueous layers were pooled to minimize pipetting. CTAB was 
replenished by the addition of 0.1× volume of 10% CTAB solution (pre-heated to 65oC 
to re-dissolve any CTAB precipitate). The mixture was mixed gently by inversion and 
re-extracted with roughly equal volume of chloroform. Nucleic acids were precipitated 
by mixing with 0.5× vol. of SPRI buffer (20% PEG6000, 2.5 M NaCl, 10 mM Tris-HCl, 
1 mM EDTA, 0.05% Tween-20, pH 8) and pelleted at 17900×g, room temperature for 
30 mins, desalt by washing with 70% ethanol after complete removal of the supernatant, 
re-spun, air-dried, and re-dissolved in 10 µL freshly dispensed Milli-Q water. 
Dissolution was carried out at 65oC for ca. 15 mins in an incubator, then cooled on ice. 
RNA degradation was carried out by the addition of RNase A (Wako Pure Chemical 
Industries) to a final concentration of 1 µg/µL and incubation at 37oC for 60 mins. To 
check the DNA integrity and quantity, 0.5 µL of the extracted genomic DNA was 
electrophoresized in 1% agarose gel, 0.5× TAE. The purified DNA was immediately 
 78 
subjected to downstream enzymatic treatment or bisuflite conversion without being 
stored frozen. Under these conditions, all of the purified sample DNA achieved bisulfite 
conversion rate of about 99%. 
 
General procedure: Genotyping 
Founder F0 medaka with indel mutation at the targeted locus were identified by routine 
genotyping procedure. Genomic DNA was crudely extracted from fin clip using the 
“HotSHOT” method: fin clip was completely submerged and lysed in lysis solution 
(25mM NaOH, 0.2mM EDTA) at 95oC for 15 mins. The crude lysate was cooled down 
to 4oC, then neutralized with equal volume of 40 mM Tris-HCl, pH 8, mixed and 
centrifuged briefly. The supernatant was directly pipetted from the liquid surface and 
used as PCR template. The target locus was amplified by routine PCR with amplicon 
size < 500 bp. The PCR product was then denatured at 95oC for 2mins, then renatured 
by ramped down to 25oC at a rate of -0.1oC/second. One µL of the renatured product 
was digested with 0.5 units of T7 Endonuclease I (T7E1) in 5 µL 1× NEB Buffer 2 at 
37oC for 30 mins. To generate wild-type control, the same procedures were repeated 
using wild-type fish (i.e. not injected with CRISPR). The digestion products were 
electrophoresed in 2% agarose gel. Presence of indel would result in extra bands 
(relative to the control) at lower molecular weights, due the formation of heteroduplex, 
which was cleaved by T7E1, after renaturation. 
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Appendix 
Table 2    List of HypoMDs used for testing the anticipated governing role of 
(CG)3 and CG-null repeats on local methylation state. 
Locus 1–3 contain single (CG)3 motif, whereas Locus 4–6 contain single CGnull-
repeat motif. The motifs are in close proximity to spCas9’s PAM (5’-NGG-3’), allowing 
efficient knockout using CRISPR. 
 
Locus Genome coordinate sgRNA guide sequence (5’ to PAM) 
1 chr2:3940468-3940729 GTGACGCAAATCCGCGCG 
2 chr 5:2430624-2430994 GGGCGCTAGGACCGCGCG 
3 chr 6:18690493-18691397 CCGCACTTTCTCCGCGCG 
4 chr 17:5828017-5828757 TGACAGCCAGCTAGCTCG 
5 chr 10:25324929-25325607 GTGCTAATGCAAGCTAGC 
6 chr 13:14404288-14405391 TTGTAGTTGTTGCTAGCT 
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Table 3    List of oligo used. 
 
Name Sequence (5’ to 3’) 
F3-01F GGAGTGAAGGAGGTTAGGGGTAAGT 
F3-01R AAAAACCATAAAACCCTATACCTAATCTATC 
F3-02top ACACTCTTTCCCTACACGACGCTCTTCCGATC-phosphorothioate-T 
F3-02bottom 5’phosphate-GATCGGAAGAGCTCGTATGCCGTCTTCTGCTTG 
F3-03F NNNNNNTAGGGATAACAGGGTAATGGAGTGAAGGAGGTTAGGG- 
-GTAAGTACACTCTTTCCCTACACGACGCTCTTCCGATCT 
F3-03R NNNNNNTAGGGATAACAGGGTAATAAAAACCATAAAACCCTATA- 
-CCTAATCTATCCAAGCAGAAGACGGCATACGAGCTCTTCCGATCT 
F3-04F AAAAGTCTCAACACTGCCTCC 
F3-04R AGAGCCTTCCATGTTTGACC 
F4-01F GCCGCCACCATGGATACCTA 
F4-01R CTATCACACTTTCCGCTTTTTCT 
F4-02F GGTTAGGGGTAAGTAGATCTGAATTAAAGAAAGTTCTACAAAC 
F4-02R ATACCTAATCTATCAGATCTACATCATCCTCTTCATCATTGA 
F4-03F GGTTAGGGGTAAGTAGATCTGGGCAGAAACGCATTTTGGG 
F4-03R ATACCTAATCTATCAGATCTTTTGAAATTGAAAATCAAGCA 
F4-04F GGTTAGGGGTAAGTAGATCTCGGACATGCAGAGCTTCG 
F4-04R ATACCTAATCTATCAGATCTAGAAGTCTGATCCTTGTCAGA 
F4-05F GGTTAGGGGTAAGTAGATCTGCATTCTGTGCACGAGACG 
F4-05R ATACCTAATCTATCAGATCTGGGAAGAGTGGCGAGTAGTT 
F4-06F GGTTAGGGGTAAGTAGATCTGCACTCAAAGGCAGCAGG 
F4-06R ATACCTAATCTATCAGATCTAGAACATAAACATCAACCACGGT 
F4-07F GGTTAGGGGTAAGTAGATCTGGAAATAACAGCGGACTACGG 
F4-07R ATACCTAATCTATCAGATCTATCTTTTCCTCTCACGTGGC 
F4-08F GGTTAGGGGTAAGTAGATCTGATTCAAAATGCTGCCATGACG 
F4-08R ATACCTAATCTATCAGATCTATGCTAAGTGCATTAGCCGA 
F4-09F GGTTAGGGGTAAGTAGATCTGGCTAACCTCGCATAGCG 
F4-09R ATACCTAATCTATCAGATCTGTCCGGGTTGCTGCATAC 
F4-10F GGTTAGGGGTAAGTAGATCTGGGGCTCAAAGCTGCACATT 
F4-10R ATACCTAATCTATCAGATCTGTTCAGAGCGAGTCACTGC 
F4-11F GGTTAGGGGTAAGTAGATCTGACATGGCTTCCGGGTTAAA 
F4-11R ATACCTAATCTATCAGATCTACTTCCACCTGTGCGCAC 
F4-12F GGTTAGGGGTAAGTAGATCTGTCTGTGTTAACATTGAGCCCT 
F4-12R ATACCTAATCTATCAGATCTATACAAAAATTGCCGCCAAACC 
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Table 3    List of oligo used (con’t). 
 
Name Sequence (5’ to 3’) 
F5-01a GGCATTTGGAGGCAGCGATC 
F5-01b GGAAACTGGAAAGGATCTCC 
F5-01c GGACAACCAGGAGCGCATCA 
F5-01f GGACCTGATTGGGCAGAAGC 
F5-01e GGAAAGGATCTCCCGGCTGG 
F5-01f GGTGGCTCAGCTCAAGCAGA 
F5-02a GGTGAGCTCGAGGGCTGAGT 
F5-02b GGTGCATGACCAGCGGTGCT 
F5-02c GGTGACGCGGTGGGGACAGT 
F5-02d GGCAGGGCTAGCATGGCTAG 
F5-02e GGATGCTAACCTCCTCAACT 
F5-02f GGAAAATGACCGAGTTGAGG 
F5-03F AGAYGGTATYGGATATGTAGAGTTT 
F5-03R AAAATCTAATCCTTATCAAATACAAATA 
F5-04F AGGGAGAGGTTTAGATTTATGAT 
F5-04R AAAAAACTCTTTTAATCCCAAAATTC 
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Table 4    List of HyperMD loci synthesized and assayed for autonomy in 
methylation recapitulation. 
 
Locus Genome coordinate 
1 chr1: 3398602–3398902 
2 chr12: 8743429–8743729 
3 chr13: 153400–153700 
4 chr15: 2122812–2123112 
5 chr18: 174764–175064 
6 chr13: 4930579–4930879 
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Table 5    Endogenous origins of the integrated fragments from (left) 
unmethylated and (right) artificially methylated library. 
Note that vast majority (> 96%) of the assayed fragments were completely derived 
from either inside or outside DNase I hypersensitive sites (DHS). 
 
Origin Unmethylated Pre-methylated 
Outside DHSs 7239 
(78.7%) 
12791 
(79.3%) 
Inside DHSs 1622 
(17.6%) 
2775 
(17.2%) 
Edges of DHSs 332 
(3.6%) 
568 
(3.5%) 
Total 9193 16134 
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